<SEC-DOCUMENT>0001213900-25-102145.txt : 20251024
<SEC-HEADER>0001213900-25-102145.hdr.sgml : 20251024
<ACCEPTANCE-DATETIME>20251024160128
ACCESSION NUMBER:		0001213900-25-102145
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20251022
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251024
DATE AS OF CHANGE:		20251024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Spectral AI, Inc.
		CENTRAL INDEX KEY:			0001833498
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40058
		FILM NUMBER:		251416124

	BUSINESS ADDRESS:	
		STREET 1:		2515 MCKINNEY AVE #1000
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		(212) 492-3000

	MAIL ADDRESS:	
		STREET 1:		2515 MCKINNEY AVE #1000
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosecliff Acquisition Corp I
		DATE OF NAME CHANGE:	20201123
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0262315-8k_spectral.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:mdai="http://spectral-ai.co/20251022">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_mdai_spectral%2Dai.co_20251022 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20251022_20251022 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001833498 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000004" name="dei:EntityCentralIndexKey">0001833498</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mdai-20251022.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001833498</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-22</xbrli:startDate>
        <xbrli:endDate>2025-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001833498</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdai:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-22</xbrli:startDate>
        <xbrli:endDate>2025-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001833498</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdai:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-22</xbrli:startDate>
        <xbrli:endDate>2025-10-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20251022__20251022_zdlPOjjS0pP"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_906_edei--DocumentPeriodEndDate_c20251022__20251022_zEUnrpVz5lcf"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October 22, 2025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="text-transform: uppercase"><b><span id="xdx_90F_edei--EntityRegistrantName_c20251022__20251022_zZUqneESDXDa"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000011" name="dei:EntityRegistrantName">SPECTRAL AI, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 32%; text-align: center"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20251022__20251022_zj7K7nPEgSQ4"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 32%; text-align: center"><b><span id="xdx_90E_edei--EntityFileNumber_c20251022__20251022_znJXtrhcwCp5"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000013" name="dei:EntityFileNumber">001-40058</ix:nonNumeric></span></b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 32%; text-align: center"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20251022__20251022_z209thLjoa6a"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000014" name="dei:EntityTaxIdentificationNumber">85-3987148</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="border-top: black 1.5pt solid; vertical-align: top; text-align: center">(State or other jurisdiction<br/>
of incorporation)</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-top: black 1.5pt solid; vertical-align: top; text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-top: black 1.5pt solid; vertical-align: top; text-align: center">(I.R.S. Employer<br/>
Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20251022__20251022_zzrsEKBxVIXf"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000015" name="dei:EntityAddressAddressLine1">2515 McKinney Avenue</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20251022__20251022_z8ueIXizMk7g"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 1000</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20251022__20251022_zG5ea23mbPi4"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000017" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20251022__20251022_zPB8wv9c0v3l"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></p></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 49%; text-align: center"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20251022__20251022_z8U5AMk2OMje"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000019" name="dei:EntityAddressPostalZipCode">75201</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="border-top: black 1.5pt solid; vertical-align: top; text-align: center">(Address of principal executive offices)</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-top: black 1.5pt solid; vertical-align: top; text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90A_edei--CityAreaCode_c20251022__20251022_zaGO8T8oKeXc"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000020" name="dei:CityAreaCode">972</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20251022__20251022_zL9DQqFHFjci"><ix:nonNumeric contextRef="AsOf2025-10-22" id="Fact000021" name="dei:LocalPhoneNumber">499-4934</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--WrittenCommunications_c20251022__20251022_z2PLNmzCYiz2"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communication pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--SolicitingMaterial_c20251022__20251022_zlqkh20zL3Dk"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20251022__20251022_z48j7EixPSB8"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20251022__20251022_zWyvfIs95Lm6"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencements communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 34%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"><b>Trading Symbols</b></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="white-space: nowrap; width: 32%; text-align: center"><b>Name of each exchange on <br/>
which registered</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="border-top: black 1.5pt solid; text-align: center"><b><span id="xdx_90C_edei--Security12bTitle_c20251022__20251022__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zbzWwQ3mntLa"><ix:nonNumeric contextRef="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-top: black 1.5pt solid; text-align: center"><b><span id="xdx_909_edei--TradingSymbol_c20251022__20251022__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zgMIVPzKkqC1"><ix:nonNumeric contextRef="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember" id="Fact000027" name="dei:TradingSymbol">MDAI</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-top: black 1.5pt solid; text-align: center"><b>The <span id="xdx_90D_edei--SecurityExchangeName_c20251022__20251022__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zZhi7GC1ZJBa"><ix:nonNumeric contextRef="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><b><span id="xdx_904_edei--Security12bTitle_c20251022__20251022__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_zbClRxFOOoel"><ix:nonNumeric contextRef="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" id="Fact000029" name="dei:Security12bTitle">Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><b><span id="xdx_907_edei--TradingSymbol_c20251022__20251022__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_zxw4PHzDaEb1"><ix:nonNumeric contextRef="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" id="Fact000030" name="dei:TradingSymbol">MDAIW</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><b>The <span id="xdx_90D_edei--SecurityExchangeName_c20251022__20251022__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_zmp5F7mWYHJ6"><ix:nonNumeric contextRef="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20251022__20251022_zntZD08oqed6"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityExTransitionPeriod_c20251022__20251022_zISii2JDf3G2"><ix:nonNumeric contextRef="AsOf2025-10-22" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Securities Purchase Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 22, 2025, Spectral AI, Inc. (the &#8220;Company&#8221;)
entered into a securities purchase agreement&#160;(the &#8220;Purchase Agreement&#8221;) with&#160;a certain investor (the &#8220;Investor&#8221;)
for the sale of&#160;3,065,000&#160;shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.0001 per share
(&#8220;Common Stock&#8221;), at an offering price of $1.90 per Share (such transaction, the &#8220;Offering&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sale and issuance of the Shares is being made
pursuant to the Company&#8217;s registration statement on Form S-3 (file number 333-282681) (the &#8220;Registration Statement&#8221;),
filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on October 16, 2024 and declared effective on October 31, 2024,
and the Company&#8217;s prospectus supplement relating to the Offering, which was filed with the SEC on October 23, 2025, that forms part
of the Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, in a concurrent private placement
pursuant to the Purchase Agreement (the &#8220;Private Placement&#8221;), the Company agreed to sell to the Investor (i) warrants (the
&#8220;Warrants&#8221;) to purchase up to 4,000,000 shares of our Common Stock, and (ii) pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;)
to purchase up to 935,000 shares of our Common Stock. Each Warrant has an exercise price per share of $2.51, will exercisable on the earlier
of (a) the effective date of stockholder approval (the &#8220;Stockholder Approval&#8221;) for the issuance of shares of Common Stock
underlying the Warrants (the &#8220;Stockholder Approval Date&#8221;) and (b) the date that is six months following the issuance date
of the Warrants (the earlier of the dates specified in (a) and (b), the &#8220;Initial Exercise Date&#8221;) and will have a term of five
(5) years from the initial issuance date. Each Pre-Funded Warrant has a purchase price of $1.8999, an exercise price per share of $0.0001,
is exercisable immediately and may be exercised at any time until such Pre-Funded Warrant is exercised in full. The Warrants and the Pre-Funded
Warrants, along with the shares of Common Stock issuable upon the exercise of the Warrants and the Pre-Funded Warrants, are being offered
pursuant to the exemptions provided in Section 4(a)(2) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement&#160;contains customary
representations, warranties and agreements by the Company and the Investor and customary closing conditions. Additionally, in connection
with the Offering and the Private Placement, we entered into a registration rights agreement with the Investor that granted certain registration
rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Terms of the Pre-Funded Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Pre-Funded Warrants have an exercise price
of $0.0001 per share of Common Stock, will be exercisable upon issuance and will expire when exercised in full. At any time, the holder
may, in its sole discretion, elect to exercise the Pre-Funded Warrants through a cashless exercise, in which case the holder would receive
upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the Pre-Funded Warrants,
and the number of Pre-Funded Warrant Shares, will be subject to adjustment in the event of any stock dividend or split, reverse stock
split, recapitalization, reorganization or similar transaction, as described in the Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder will not have the right to exercise any
portion of the Pre-Funded Warrants if the holder (together with its affiliates) would beneficially own in excess of 9.99% of the number
of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of such warrants. However, any holder may increase or decrease such percentage up to 9.99%, provided that any increase
will not be effective until the 61st day after the election.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a Fundamental Transaction (as
such term is defined in the Pre-Funded Warrants), the successor entity will succeed to, and be substituted for the Company, and may exercise
every right and power that the Company may exercise and will assume all of its obligations under the Pre-Funded Warrants with the same
effect as if the successor entity had been named in the warrant itself. If holders of Common Stock are given a choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the holder will be given the same choice as to the consideration it
receives upon any exercise of the Pre-Funded Warrants following the Fundamental Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Pre-Funded
Warrants or by virtue of such holder&#8217;s ownership of shares of Common Stock, the holder of Pre-Funded Warrants will not have the
rights or privileges of a holder of Common Stock, including any voting rights, until the holder exercises the Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Terms of the Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants have an exercise price of $2.51 per
share of Common Stock and will be exercisable commencing on the Initial Exercise Date and will expire on the fifth anniversary of the
issuance dates of the Warrants. The Company has agreed to obtain Stockholder Approval at the next meeting of stockholders with the recommendation
of the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) that such proposal be approved. If the Company does not obtain Stockholder
Approval by June 1, 2026, the Company will call a meeting every 90 days thereafter to seek Stockholder Approval until the date Stockholder
Approval is obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If at any time after the Stockholder Approval
Date, a registration statement registering the issuance of the Common Warrant Shares under the Securities Act is not effective or available,
the holder may, in its sole discretion, elect to exercise the Warrants through a cashless exercise, in which case the holder would receive
upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the Warrants, and the number
of Warrant Shares, will be subject to adjustment in the event of any stock dividend or split, reverse stock split, recapitalization, reorganization
or similar transaction, as described in the Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder will not have the right to exercise any
portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares
of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of the warrants. However, any holder may increase or decrease such percentage up to 9.99%, provided that any increase will
not be effective until the 61st day after the election.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a Fundamental Transaction (as
such term is defined in the Warrants), the successor entity will succeed to, and be substituted for the Company, and may exercise every
right and power that the Company may exercise and will assume all of its obligations under the Warrants with the same effect as if the
successor entity had been named in the warrant itself. If holders of Common Stock are given a choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the holder will be given the same choice as to the consideration it receives upon any
exercise of the Warrants following the Fundamental Transaction. In addition, the successor entity, at the request of holders of Warrants,
will be obligated to purchase any unexercised portion of the Warrants in accordance with their terms. Notwithstanding the foregoing, in
the event of a Fundamental Transaction, the holders of the Warrants have the right to require the Company or a successor entity to redeem
the Warrants for cash in the amount of the Black Scholes Value (as defined in the Warrants) of the unexercised portion of the Warrants
concurrently with or within thirty (30) days following the consummation of a Fundamental Transaction. However, in the event of a Fundamental
Transaction that is not in the Company&#8217;s control, including a Fundamental Transaction not approved by the Company&#8217;s board
of directors, the holders of the Warrants will only be entitled to receive from the Company or its successor entity the same type or form
of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of the Warrant that is being offered
and paid to the holders of Common Stock in connection with the Fundamental Transaction, whether that consideration is in the form of cash,
stock or any combination of cash and stock, or whether the holders of Common Stock are given the choice to receive alternative forms of
consideration in connection with the Fundamental Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Warrants or
by virtue of such holder&#8217;s ownership of shares of Common Stock, the holder of Warrants will not have the rights or privileges of
a holder of Common Stock, including any voting rights, until the holder exercises the Warrants</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Placement Agency&#160;Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 22, 2025, the Company also entered
into a&#160;placement agency agreement (the&#160;&#8220;Placement Agency Agreement&#8221;) with Northland Securities, Inc. (&#8220;Northland&#8221;),
pursuant to which Northland agreed to act as the Company&#8217;s sole placement agent in connection with the Offering, on a reasonable
best efforts basis. The Placement Agency Agreement does not give rise to any commitment by Northland to purchase any of the securities,
and Northland will have no authority to bind us by virtue of the Placement Agency Agreement. Northland has no commitment to buy any of
the securities offered pursuant to the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate gross proceeds to the Company from
the issuance and sale of the Shares in the Offering and the Warrants and the Pre-Funded Warrants in the Private Placement was approximately
$7,600,000, before deducting Northland&#8217;s fees and expenses, and other expenses incurred in connection with the Offering and the
Private Placement that are payable by the Company. The closing of both the Offering and the Private Placement occurred on October 24,
2025. The Company currently intends to use the net proceeds from the Offering and the Private Placement for working capital and general
corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company agreed to pay Northland a cash fee
of 6.00% of the aggregate gross proceeds from the sale of the Shares in the Offering. The Company also agreed to reimburse Northland for
certain expenses incurred in connection with the Offering, including its reasonable fees and expenses of legal counsel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Placement Agency Agreement, the
Company agreed to indemnify Northland against certain liabilities, including liabilities under the Securities Act, and to contribute to
payments Northland may be required to make in respect thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Registration Rights Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering and the Private
Placement, on October 24, 2025, the Company and the Investor also entered into a Registration Rights Agreement (the &#8220;Registration
Rights Agreement&#8221;), pursuant to which, within ten (10) days of the date of the Purchase Agreement, the Company is required to file
a registration statement on Form S-3 (the &#8220;Registration Statement&#8221;) with the SEC to register the Registrable Securities (as
defined in the Registration Rights Agreement). The Company also agreed to use its commercially reasonable efforts to cause the Registration
Statement to become effective no later than the earlier of (A) five (5) business days after the SEC informs the Company that no review
of such Registration Statement will be made or that the SEC has no further comments on such Registration Statement or (B) the 90th day
after the date of the Purchase Agreement (or the 120th day after the of the Purchase Agreement if the SEC reviews such Registration Statement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registration Rights Agreement contains standard
representations, warranties, covenants, indemnification and other terms customary in similar transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the legal opinion of Reed Smith LLP,
legal counsel to the Company, relating to the validity of the Shares in connection with the Offering is filed as Exhibit 5.1 to this Current
Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Current Report on Form 8-K shall not constitute
an offer to sell or the solicitation of an offer to buy securities, nor shall there be any offer, solicitation or sale of securities in
any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the
securities laws of any such state or other jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the Pre-Funded Warrant,
the Warrant, Purchase Agreement, the Placement Agency Agreement and Registration Rights Agreement do not purport to be complete and are
qualified in their entirety by reference to such documents (or forms thereof), which are filed&#160;as Exhibit 4.1, 4.2, 10.1, 10.2 and
10.3, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information included in Item 1.01 of this
Current Report on Form 8-K regarding the Private Placement&#160;is incorporated by reference into this Item 3.02 of this Current Report
on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants and Pre-Funded Warrants being sold
to the Investor will be issued in reliance on the exemptions provided in Section 4(a)(2) under the&#160;Securities Act.&#160;Accordingly,
the Investor may only resell the Warrants, Pre-Funded Warrants and the shares of Common Stock issuable upon exercise of the Warrants and
Pre-Funded Warrants, pursuant to an effective registration statement under the Securities Act covering the resale of such shares of Common
Stock, an exemption under Rule 144 under the Securities Act or another applicable exemption under the Securities Act and any applicable
state securities laws.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7.01. Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 23, 2025, the Company issued a press
release announcing the pricing of the Offering, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this Item 7.01 to this Current
Report on Form 8-K, and in Exhibit 99.1 furnished herewith, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section,
nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This report contains forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended,
and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include statements related
to the completion of the registered direct offering, the satisfaction of customary closing conditions related to the registered direct
offering, the intended use of proceeds from the registered direct offering and other statements that are not statements of historical
fact and, in some cases, may be identified by words like &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221;
&#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221;
&#8220;predict,&#8221; &#8220;project,&#8221; &#8220;future,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;seek&#8221;
and similar terms or phrases. The forward-looking statements contained in this press release are based on management&#8217;s current expectations,
which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of the
Company&#8217;s control. Important factors that could cause the Company&#8217;s actual results to differ materially from those indicated
in the forward-looking statements are more fully discussed in the Company&#8217;s periodic filings with the SEC, including the risk factors
described under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s annual report on Form 10-K for the year ended December 31,
2024 filed with the SEC on March 31, 2025, and other documents subsequently filed with or furnished to the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement made in this Current
Report on Form 8-K speaks only as of the date hereof. Factors or events that could cause the Company&#8217;s actual results to differ
from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except
as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new
information, future developments or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 9%"><b>Exhibit Number</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%"><b>Exhibit Description</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>4.1</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex4-1_spectral.htm"><b>Form of Warrant.</b></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>4.2</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex4-2_spectral.htm"><b>Form of Pre-Funded Warrant</b></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>5.1</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex5-1_spectral.htm"><b>Opinion of Reed Smith LLP.</b></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>10.1</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex10-1_spectral.htm"><b>Form of Securities Purchase Agreement, dated October 22, 2025.</b></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>10.2</b></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea026231501ex10-2_spectral.htm"><b>Placement Agency Agreement, dated October 22, 2025, by and between Spectral AI, Inc. and Northland Securities, Inc.</b></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>10.3</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex10-3_spectral.htm"><b>Registration Rights Agreement, dated October 24, 2025.</b></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>23.1</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex5-1_spectral.htm"><b>Consent of Reed Smith LLP (contained in Exhibit 5.1).</b></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><b>99.1</b></td>
    <td>&#160;</td>
    <td><a href="ea026231501ex99-1_spectral.htm"><b>Press Release issued by Spectral AI, Inc. on October 23, 2025</b></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><b>104</b></td>
    <td>&#160;</td>
    <td><b>Cover Page Interactive Data File (formatted as Inline XBRL).</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: October 24, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>SPECTRAL AI, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 6%">By:</td>
    <td style="border-bottom: black 1.5pt solid; width: 34%">/s/ Vincent S. Capone</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:&#160;</td>
    <td>Vincent S. Capone</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>Chief Financial Officer and General Counsel</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyFkd1uwjAMhZ+Ad7AqLhGkmdgk7hgCNA1GBRPsNhR3RLRx5YS/R9pbLmnVsWmTVkWqYp/jz3aiqBNNaaJzZHh7XM7gFYsyVw5hiRkymhS9YvT0PAD/X+K7to6VcdW1MY7Ie9B77rtS+XilPGmLuwHEoifverIPQg76fUjmUSvkR2QyvUPjtMpBmR0kTCVrdIqvdYVXdSFDxbUirZGtJuPLdUWd/gApYgkvdFJn4oOF2WwUtTrV14qmTMfSq8YXhyY4YZxj4XG2dt9O1U16tI6KwRJ3iIXa5rhRHKa0Y5XuN3v6CowvyKm2QTIhXhhc7RXjIvMbKMisHKWHYSPChHXqc7L70E+QK+Uciy2yJ8ZCylgMRbOtBgwNuQPo2XAOcDjXQcAbHjJiIINgQ12gDOoeoGqiA8r5tTYGhDL0ElTt0A6U/tUq4x9b+DZLonit8iOKrhAi/meIn/xSMZyCF9q1+zfzE5FHx9k= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea026231501ex4-1_spectral.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 4.1</B></P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B><I>Execution Copy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">NEITHER THE OFFER AND SALE OF
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">COMMON STOCK PURCHASE WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SPECTRAL AI, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Warrant Shares: 4,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Issue Date: October 24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Hudson Bay Master Fund Ltd. or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date that is the earlier of (i) the Stockholder Approval Date (as
defined below) and (ii) the date that is six months following the Issue Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;), and
on or prior to 5:00 p.m. (New York City time) on October 23, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to
subscribe for and purchase from Spectral AI, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 4,000,000 shares
(as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of common stock, par value $0.0001 per share, of the
Company (&ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to
the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated October 22, 2025, among the Company and the purchasers signatory
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in accordance
with the notice requirements set forth in Section 5(h) (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price (as defined below) for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank, in either case in immediately
available funds, unless the cashless exercise procedure specified in Section 2(c) below is applicable and specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. The Company shall have no obligation to inquire with respect to or otherwise
confirm the authenticity of the signature(s) contained on any Notice of Exercise nor the authority of the person so executing such Notice
of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation promptly following the date on which the final
Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number
of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased in connection with such partial exercise. The Holder and the
Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
to the Holder any objection to any Notice of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by
acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion
of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the
amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $2.51, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: right">&nbsp;</TD>
                            <TD STYLE="width: 0.25in; text-align: center">(A)</TD><TD STYLE="text-align: justify; width: 0.25in">=</TD>
                                                                                       <TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Closing Price of
the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the
applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and
is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on
a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such
Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after
the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: center"></TD>
                            <TD STYLE="width: 0.25in; text-align: center">(B)</TD><TD STYLE="text-align: justify; width: 0.25in">=</TD>
                                                                                        <TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"></TD>
                            <TD STYLE="width: 0.25in; text-align: right">(X)&nbsp;</TD><TD STYLE="text-align: justify; width: 0.25in">=</TD>
                                                                                       <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the characteristics of the Warrants being exercised, and for purposes of Rule 144, the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position
contrary to this Section 2(c), except to the extent required by applicable law, rule or regulation. For the avoidance of doubt, the cashless
exercise procedure specified in this Section 2(c) shall not be first available prior to the deadline for effectiveness of the Registration
Statement (as defined in the Registration Rights Agreement) set forth in Section 2(c)(i) of the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the closing price of the Common Stock on the nearest preceding date on the Trading Market
on which the Common Stock is then listed or quoted as reported by Bloomberg L.P., (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the volume weighted average closing price of the Common Stock for the preceding five (5) trading
days) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P., (b) if OTCQB or OTCQX
is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on
OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for
the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of
reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market
value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in
interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> d) <U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a
participant in such system and either (A) there is an effective registration statement covering the resale of the Warrant Shares by
the Holder or (B) in the case of a cashless exercise of the Warrant, the Warrant Shares are eligible for resale by the Holder
without volume or manner-of-sale limitations pursuant to Rule 144, and otherwise, or at the request of the Holder, in electronic
book entry form to the account of the Holder or by physical delivery of a certificate, registered in the Company&rsquo;s share
register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the later of (x) the earlier of
(i) one (1) Trading Day after delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period subject to the delivery to the Company of the Notice of Exercise and (y) the time of delivery of the
aggregate Exercise Price to the Company (other than in the case of a cashless exercise) (such date, the &ldquo;<U>Warrant Share
Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of
delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received by the Warrant Share Delivery Date, provided that the Holder shall be deemed to have waived any voting rights
of any such Warrant Shares that may arise during the period commencing on such Exercise Date, through, and including, such
applicable Warrant Share Delivery Date, as necessary, such that the aggregate voting rights of any shares of Common Stock (including
such Warrant Shares) beneficially owned by the Holder and/or any Attribution Parties, collectively shall not exceed the Beneficial
Ownership Limitation (as defined below) as a result of any such exercise of this Warrant. If the Company fails for any reason to
deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay
to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day commencing on the
second Trading Day following the Warrant Share Delivery Date (increasing to $20 per Trading Day on the fifth Trading Day after such
liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are
delivered to the Holder or the Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the Fast Automated Securities Transfer program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the
Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date (subject to receipt of the aggregate exercise price for the applicable exercise (other than in the
case of a cashless exercise)), then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder or its agent or attorney and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall, to the extent applicable, pay all Transfer Agent fees required for processing of any Notice of Exercise
and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for
electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the
Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is not representing to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith and the calculations required under this Section 2(e). To the extent that the
limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of this Warrant that are in non-compliance with the Beneficial Ownership Limitation,
except to the extent the Holder relies on the number of outstanding shares of Common Stock that was provided by the Company. In
addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of
outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the
Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice from the Company or the Transfer Agent to the Holder setting forth
the number of shares of Common Stock outstanding. Upon the written request of a Holder, the Company shall within one (1) Trading Day
confirm in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon written notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not
be effective until the 61<FONT STYLE="font-size: 10pt">st</FONT> day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Notwithstanding
anything to the contrary contained herein, the Company shall not effect any exercise of this Warrant, and the Holder shall not be
entitled to exercise this Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving
effect to such exercise, would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for purposes
of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, including any &ldquo;group&rdquo; of
which the Holder is a member, to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Company
following such exercise, or (ii) the combined voting power of the securities of the Company beneficially owned by the Holder and its
Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for purposes
of Section 13(d) of the Exchange Act to exceed 9.99% of the combined voting power of all of the securities of the Company then
outstanding following such exercise. For purposes of this Section 2(e), the aggregate number of shares of Common Stock or voting
securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock
would be aggregated with the Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act shall include the shares of Common
Stock issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of
this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other
securities of the Company that do not have voting power (including without limitation any securities of the Company which would
entitle the holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, right,
option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles
the holder thereof to receive, Common Stock), are subject to a limitation on conversion or exercise analogous to the limitation
contained herein and are beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of
Common Stock would be aggregated with the Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in
shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon
exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, or
(iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the
Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding
treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of
Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be
proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to
receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">b) <U>Adjustment
Upon Issuance of Shares of Common Stock</U>. In addition to any adjustments pursuant to Section 3(a) above, if the Company, at any
time prior to the two-year anniversary of the Stockholder Approval Date, shall sell, enter into an agreement to sell or grant any
option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or
any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than
the Exercise Price then in effect (such lower price, the &ldquo;<U>Base Share Price</U>&rdquo; and such issuances collectively, a
&ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the Common Stock or Common Stock
Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion,
exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such
issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such
issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price), then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price
shall be reduced and only reduced to equal the Base Share Price; <I>provided, however</I>, that in no event shall the Exercise Price
be reduced to an amount less than $0.48 (subject to adjustment for reverse and forward stock splits, recapitalizations and similar
transactions following the date of the Purchase Agreement) (the &ldquo;<U>Floor Price</U>&rdquo;). Notwithstanding the foregoing, if
one or more Dilutive Issuances occurred prior to the Stockholder Approval Date, instead of the foregoing adjustment being made on
the date of the Dilutive Issuance, the Exercise Price will automatically be reduced immediately following the Stockholder Approval
Date to equal the greater of (i) lowest Base Share Price with respect to any Dilutive Issuance that occurred prior to the
Stockholder Approval Date and (ii) the Floor Price. The Company shall notify the Holder, in writing, no later than the Trading Day
following the issuance or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating
therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such
notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a
Dilutive Issuance Notice pursuant to this Section 3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to
receive a number of Warrant Shares based upon the Base Share Price regardless of whether the Holder accurately refers to the Base
Share Price in the Notice of Exercise. If the Company enters into a Variable Rate Transaction, the Company shall be deemed to have
issued Common Stock or Common Stock Equivalents at the lowest possible price, conversion price or exercise price at which such
securities may be issued, converted or exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">i.
<U>Issuance of Convertible Securities</U>. If the Company, at any time prior to the two-year anniversary of the Stockholder Approval Date,
in any manner issues or sells (or enters into any agreement to issue or sell) any securities (directly or indirectly) convertible into
or exchangeable for Common Stock (&ldquo;<U>Convertible Securities</U>&rdquo;) and the lowest price per share for which one share of Common
Stock is at any time issuable upon the conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof is less than
the Base Share Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company
at the time of the issuance or sale (or the time of execution of such agreement to issue or sell, as applicable) of such Convertible Securities
for such price per share. For the purposes of this Section 3(b)(ii), the &ldquo;lowest price per share for which one share of Common Stock
is at any time issuable upon the conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal
to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to
one share of Common Stock upon the issuance or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible
Security and upon conversion, exercise or exchange of such Convertible Security or otherwise pursuant to the terms thereof and (y) the
lowest conversion price set forth in such Convertible Security for which one share of Common Stock is issuable (or may become issuable
assuming all possible market conditions) upon conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus
(2) the sum of all amounts paid or payable to the holder of such Convertible Security (or any other Person) upon the issuance or sale
(or the agreement to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration received or
receivable by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no
further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise
or exchange of such Convertible Securities or otherwise pursuant to the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">ii. <U>Change
in Base Share Price or Rate of Conversion</U>. If the Base Share Price provided for in connection with any Dilutive Share or the
additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the
rate at which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or
decreases at any time (other than proportional changes in conversion or exercise prices, as applicable, in connection with an event
referred to in Section 3(a)), the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the
Exercise Price which would have been in effect at such time had such Dilutive Issuance or Convertible Securities provided for such
increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at
the time initially granted, issued or sold. For purposes of this Section 3(b)(ii), if the terms of any Dilutive Issuance or
Convertible Security (including, without limitation, any Dilutive Issuance or Convertible Security that was outstanding as of the
Purchase Agreement) are increased or decreased in the manner described in the immediately preceding sentence, then such Dilutive
Issuance or Convertible Security and the Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed
to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(b) shall be made if such
adjustment would result in an increase of the Exercise Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">iii. <U>Calculation
of Consideration Received</U>. If any Convertible Security and/or Adjustment Right is issued in connection with the issuance or sale
or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the &ldquo;<U>Primary
Security</U>&rdquo;, and such Convertible Security and/or Adjustment Right (as defined below), the &ldquo;<U>Secondary
Securities</U>&rdquo; and together with the Primary Security, each a &ldquo;<U>Unit</U>&rdquo;), together comprising one integrated
transaction, the aggregate consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the
lower of (x) the purchase price of such Unit, and (y) if such Primary Security is a Convertible Security, the lowest price per share
for which one share of Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance
with Section 3(b)(i) above and (z) the lowest VWAP of the Common Stock on any Trading Day during the five (5) Trading Day period
(the &ldquo;<U>Adjustment Period</U>&rdquo;) immediately following the public announcement of such Dilutive Issuance (for the
avoidance of doubt, if such public announcement is released prior to the opening of the principal Trading Market of the Common Stock
on a Trading Day, such Trading Day shall be the first Trading Day in such five Trading Day period and if this Warrant is exercised,
on any given Exercise Date during any such Adjustment Period, solely with respect to such portion of this Warrant converted on such
applicable Exercise Date, such applicable Adjustment Period shall be deemed to have ended on, and included, the Trading Day
immediately prior to such Exercise Date). If any shares of Common Stock or Convertible Securities are issued or sold or deemed to
have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount of consideration received
by the Company therefor. If any shares of Common Stock or Convertible Securities are issued or sold for a consideration other than
cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such
consideration consists of publicly traded securities, in which case the amount of consideration received by the Company for such
securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding
the date of receipt. If any shares of Common Stock or Convertible Securities are issued to the owners of the non-surviving entity in
connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be
the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of
Common Stock or Convertible Securities (as the case may be). The fair value of any consideration other than cash or publicly traded
securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within ten (10)
days after the occurrence of an event requiring valuation (the &ldquo;<U>Valuation Event</U>&rdquo;), the fair value of such
consideration will be determined within five (5) Trading Days after the tenth (10<SUP>th</SUP>) day following such Valuation Event
by an independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be
final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.
For purposes of this Warrant, the term &ldquo;<U>Adjustment Right</U>&rdquo; means any right granted with respect to any securities
issued in connection with, or with respect to, any issuance or sale (or deemed issuance or sale in accordance with Section 3) of
Common Stock (other than rights of the type described in Section 3(c) and 3(d) hereof) that could result in a decrease in the net
consideration received by the Company in connection with, or with respect to, such securities (including, without limitation, any
cash settlement rights, cash adjustment or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">iv. <U>Record
Date</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend
or other distribution payable in shares of Common Stock or in Convertible Securities or (B) to subscribe for or purchase shares of Common
Stock or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the shares of Common Stock
deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting
of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">v. <U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to Section 3(b), the number of Warrant Shares
that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the
aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price
in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Notwithstanding
the foregoing, no adjustment will be made under this Section 3(b) (Adjustment Upon Issuance of Shares of Common Stock) in respect of an
Exempt Issuance (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, restricted stock units or options, and the underlying shares
of Common Stock to consultants, employees, officers or directors of the Company pursuant to any stock or option plan duly adopted
for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of
non-employee directors established for such purpose for services rendered to the Company, (b) securities issued upon the exercise or
exchange of or conversion of Convertible Securities issued and outstanding on the date of this Warrant, provided that such
securities have not been amended since the date of this Warrant to increase the number of such securities or to decrease the
exercise price, exchange price or conversion price of such securities (other than in connection with stock dividends, stock splits
or combinations) or to extend the term of such securities, (c) securities issued pursuant, acquisitions or strategic transactions
approved by a majority of the directors of the Company, provided that any such issuance shall only be to a Person (or to the equity
holders of a Person) which is, itself or through its Subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and which shall reasonably be expected to provide to the Company additional benefits,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in securities, (d) securities issued pursuant to any presently outstanding warrants
disclosed in the Subscription Agreement or this Warrant, and (e) securities issued to Avenue Capital pursuant to the terms of the
Company&rsquo;s existing Loan and Security Agreement dated as of March 21, 2025, provided that such securities have not been amended
since the date of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or
conversion price of such securities (other than in connection with stock dividends, stock splits or combinations) or to extend the
term of such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) and 3(b) above, for two (2) years after the
Stockholder Approval Date, if the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants,
securities or other property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;),
then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution; provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or
indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% the outstanding
Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash
or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or
scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the
outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other
business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the securities, cash and other property of the successor or acquiring corporation (or ultimate parent
thereof) or of the Company, if it is the surviving corporation, as applicable, (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of
this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply
to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in
such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are
given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days
after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable
Fundamental Transaction), purchase this Warrant from the Holder, as described below by paying to the Holder, as described below, an
amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of the consummation of such Fundamental Transaction, provided, however, that, if the Fundamental Transaction is not within the
Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to
receive from the Company or any Successor Entity, as of the date of the consummation of such Fundamental Transaction, the same type
or form of consideration (and in the same proportion), valued at the Black Scholes Value of the unexercised portion of this Warrant,
that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether
that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the
choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such
holders of Common Stock will be deemed to have received shares of the Successor Entity (which Successor Entity may be the Company
following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of
this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as
of the day of consummation of the applicable contemplated Fundamental Transaction for pricing purposes and reflecting (A) a
risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public
announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to
the greater of (1) the 30 day volatility, (2) the 100 day volatility and (3) the 365 day volatility, each of clauses (1)-(3) as
obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately
following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such
calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash
consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the
Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the
consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request
pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black
Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i)
five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the Purchase Agreement in
accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this
Warrant immediately prior to the consummation of such Fundamental Transaction) and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the Purchase
Agreement referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant and the Purchase Agreement with the
same effect as if such Successor Entity had been named as the Company herein. For the avoidance of doubt, the Holder shall be
entitled to the benefits of the provisions of this Section 3(e) regardless of whether the Company has sufficient authorized shares
of Common Stock for the issuance of Warrant Shares and/or whether a Fundamental Transaction occurs prior to the Stockholder Approval
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> g) <U>Notice to Holder</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a
party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the
Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be
determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent
that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of
the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.
The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective
date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">g) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, with the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period of
time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">h) <U>Stockholder
Approval</U>. At the Company&rsquo;s next meeting of stockholders, the Company shall seek Stockholder Approval, with the recommendation
of the Board of Directors that such proposal be approved, and the Company shall solicit proxies from its stockholders in connection therewith
in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their
proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain such Stockholder Approval. If the Company
is unable to secure Stockholder Approval by June 1, 2026, the Company shall convene subsequent stockholder meetings no less frequently
than once every 90 days until such time as the Stockholder Approval is obtained or the Common Warrants are no longer outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with the Securities Act and any other applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form of the
Assignment Form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes
payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be
required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the
Holder shall surrender this Warrant to the Company promptly following the date on which the Holder delivers the Assignment Form
attached hereto duly executed by the Holder or its agent or attorney to the Company assigning this Warrant in full. The Warrant, if
properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, provides to the Company an opinion of counsel in form and substance reasonably satisfactory to the Company
to the effect that the transfer of this Warrant does not require registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as
expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section 2(c) herein, in no event shall the Company be required to net cash settle an exercise of this
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the
Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Except and to
the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of the Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing,
the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise
Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies (notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date). Without limiting any other provision of this Warrant, if the Company willfully
and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall
pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo;
fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">o)
<U>Electronic Signatures</U>. Electronically scanned and transmitted signatures, including by email attachment, shall be deemed originals
for all purposes of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECTRAL AI, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. Michael DiMaio, MD</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">TO: <B>SPECTRAL AI, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase _________Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">in lawful money of the United States; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">if permitted the cancellation of such number of Warrant Shares
as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number
of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The Warrant Shares shall be delivered
to the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in">(4) Accredited
Investor. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Name of Investing Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>Signature of Authorized Signatory of Investing Entity</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Date: ___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 10.55pt"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 10.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 10.55pt">FOR VALUE RECEIVED, the
foregoing Warrant and all rights evidenced thereby are hereby assigned to&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; padding-left: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 48%; border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;(Please Print)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Phone Number:</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email Address:</P></TD>
    <TD STYLE="border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">Dated: _________________
    , _____&#9;</P></TD>
    <TD STYLE="font-size: 10pt; width: 48%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">Holder&rsquo;s
    Signature:<U> _________________________________</U></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">Holder&rsquo;s
    Address:<U>&#9; _________________________________</U></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea026231501ex4-2_spectral.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">NEITHER THE OFFER AND SALE OF THIS
SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">PRE-FUNDED COMMON STOCK PURCHASE
WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>SPECTRAL AI, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Warrant Shares: 935,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Initial Exercise Date: October 24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Issue Date: October 24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify">THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the
&ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Hudson Bay Master Fund Ltd. or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and through and
including the date this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from Spectral AI, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 935,000 shares (as subject
to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of common stock, par value $0.0001 per share, of the Company
(&ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to the
Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated October 22, 2025, among the Company and the purchasers signatory
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in
accordance with the notice requirements set forth in Section 5(h) (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price (as defined
below) for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a
United States bank, in either case in immediately available funds, unless the cashless exercise procedure specified in Section 2(c)
below is applicable and specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor
shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. The Company shall
have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s) contained on any Notice of
Exercise nor the authority of the person so executing such Notice of Exercise. Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation promptly following the date on which the final Notice of Exercise is delivered to the Company. Partial
exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have
the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of
Warrant Shares purchased in connection with such partial exercise. The Holder and the Company shall maintain records showing the
number of Warrant Shares purchased and the date of such purchases. The Company shall deliver to the Holder any objection to any
Notice of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD>
                               <TD STYLE="width: 0.25in; text-align: center">&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule
600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Closing Price of the Common
Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice
of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within
two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a
Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in; text-align: left">(B)</TD>
                                         <TD STYLE="width: 0.25in; text-align: center">&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in; text-align: left">(X)</TD>
                                         <TD STYLE="width: 0.25in; text-align: center">&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the characteristics of the Warrants being exercised, and for purposes of Rule 144, the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position
contrary to this Section 2(c), except to the extent required by applicable law, rule or regulation. For the avoidance of doubt, the cashless
exercise procedure specified in this Section 2(c) shall not be first available prior to deadline for effectiveness of the Registration
Statement (as defined in the Registration Rights Agreement) set forth in Section 2(c)(i) of the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the closing price of the Common Stock on the nearest preceding date on the Trading Market
on which the Common Stock is then listed or quoted as reported by Bloomberg L.P., (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the volume weighted average closing price of the Common Stock for the preceding five (5) trading days
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. , (b) if OTCQB or OTCQX is
not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a
share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest
of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Notwithstanding anything herein to the
contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">i. <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to
the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement covering the resale of the Warrant Shares by the Holder or (B) in
the case of a cashless exercise of the Warrant, the Warrant Shares are eligible for resale by the Holder without volume or
manner-of-sale limitations pursuant to Rule 144, and otherwise, or at the request of the Holder, in electronic book entry form to
the account of the Holder or by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of
the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the
address specified by the Holder in the Notice of Exercise by the date that is the later of (x) the earlier of (i) one (1) Trading
Day after delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement
Period subject to the delivery to the Company of the Notice of Exercise and (y) the time of delivery of the aggregate Exercise Price
to the Company (other than in the case of a cashless exercise) (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the
Warrant Share Delivery Date, provided that the Holder shall be deemed to have waived any voting rights of any such Warrant Shares
that may arise during the period commencing on such Exercise Date, through, and including, such applicable Warrant Share Delivery
Date, as necessary, such that the aggregate voting rights of any shares of Common Stock (including such Warrant Shares) beneficially
owned by the Holder and/or any Attribution Parties, collectively shall not exceed the Beneficial Ownership Limitation (as defined
below) as a result of any such exercise of this Warrant. If the Company fails for any reason to deliver to the Holder the Warrant
Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as
liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common
Stock on the date of the applicable Notice of Exercise), $10 per Trading Day commencing on the second Trading Day following the
Warrant Share Delivery Date (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to
accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered to the Holder or the
Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the Fast Automated
Securities Transfer program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date (subject to receipt of the aggregate exercise price for the applicable exercise (other than in the
case of a cashless exercise)), then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder or its agent or attorney and the Company
may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall, to the extent applicable, pay all Transfer Agent fees required for processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for electronic delivery of the Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the
Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is not representing to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith and the calculations required under this Section 2(e). To the extent that the
limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of this Warrant that are in non-compliance with the Beneficial Ownership Limitation,
except to the extent the Holder relies on the number of outstanding shares of Common Stock that was provided by the Company. In
addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of
outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the
Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice from the Company or the Transfer Agent to the Holder setting forth
the number of shares of Common Stock outstanding. Upon the written request of a Holder, the Company shall within one (1) Trading Day
confirm in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon written notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not
be effective until the 61<FONT STYLE="font-size: 10pt">st</FONT> day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Notwithstanding anything to the contrary
contained herein, the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise this
Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect to such exercise, would
cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder and its Affiliates and any other Persons
whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for purposes of Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder, including any &ldquo;group&rdquo; of which the Holder is a member, to
exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Company following such exercise, or (ii)
the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons
whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for purposes of Section 13(d) of the Exchange
Act to exceed 9.99% of the combined voting power of all of the securities of the Company then outstanding following such exercise.
For purposes of this Section 2(e), the aggregate number of shares of Common Stock or voting securities beneficially owned by the
Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the
Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act shall include the shares of Common Stock issuable upon the exercise
of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which
would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y)
exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not
have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at
any time Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at
any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock),
are subject to a limitation on conversion or exercise analogous to the limitation contained herein and are beneficially owned by the
Holder or any of its Affiliates and other Persons whose beneficial ownership of Common Stock would be aggregated with the
Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends and
Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a
distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of
this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock
outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section
3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such
dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">b) <U>Subsequent Rights
Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, for two (2) years after the Stockholder Approval Date,
if the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the
Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this
Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase
Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to
such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right
thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;Distribution&rdquo;), at any time after the issuance
of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the
Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of
this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution; provided, however, that, to
the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of
any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or
indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% the outstanding
Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash
or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or
scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the
outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other
business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the securities, cash and other property of the successor or acquiring corporation (or ultimate parent
thereof) or of the Company, if it is the surviving corporation, as applicable, (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of
this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply
to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in
such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are
given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the
Purchase Agreement in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a
corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and
the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction) and which is
reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of
this Warrant and the Purchase Agreement referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may
exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
Purchase Agreement with the same effect as if such Successor Entity had been named as the Company herein. For the avoidance of
doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of whether the Company has
sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or whether a Fundamental Transaction occurs
prior to the Issue Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> f) <U>Notice to Holder</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver
to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">ii. Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or
substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or
property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the
Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear
upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with the Securities Act and any other applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form of the
Assignment Form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes
payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be
required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the
Holder shall surrender this Warrant to the Company promptly following the date on which the Holder delivers the Assignment Form
attached hereto duly executed by the Holder or its agent or attorney to the Company assigning this Warrant in full. The Warrant, if
properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, provides to the Company an opinion of counsel in form and substance reasonably satisfactory to the Company
to the effect that the transfer of this Warrant does not require registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">a) <U>No Rights as Stockholder
Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.
Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Except and to the extent as waived or consented
to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or
through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of the Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing,
the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use
commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies (notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date). Without limiting any other provision of this Warrant, if the Company willfully
and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall
pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo;
fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">o)
<U>Electronic Signatures</U>. Electronically scanned and transmitted signatures, including by email attachment, shall be deemed originals
for all purposes of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this Warrant to be
executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECTRAL AI, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. Michael DiMaio, MD</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">TO: <B>SPECTRAL AI, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(1) The undersigned hereby
elects to purchase ___________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in
full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">in lawful money of the United States; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">if permitted the cancellation of such number of Warrant Shares
as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number
of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The Warrant Shares shall be delivered
to the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1in">(4) Accredited
Investor. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Name of Investing Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><I>Signature of Authorized Signatory of Investing Entity</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Date: ______________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 10.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; padding-left: 2.5pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 48%; border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Phone Number:</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"> Email Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:  _______________, _______</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holder&rsquo;s Signature: ________________________________</P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holder&rsquo;s Address:  _________________________________</P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea026231501ex5-1_spectral.htm
<DESCRIPTION>OPINION OF REED SMITH LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 49%"><IMG SRC="ex5-1_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Reed Smith LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">599 Lexington Avenue<BR>
    New York, NY 10022-7650</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">+1 212 521 5400</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Fax +1 212 521 5450</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">reedsmith.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 23, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Spectral AI, Inc.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2515 McKinney Avenue, Suite 1000&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dallas, Texas 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as special counsel to Spectral AI,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in connection with the offer and sale by the Company of 3,065,000 shares
(the &ldquo;<B>Shares</B>&rdquo;) of the Company&rsquo;s common stock, par value $0.0001 per share pursuant to (i) that certain Securities
Purchase Agreement, dated October 22, 2025 by and among the Company and certain investors party thereto (the &ldquo;<B>Subscription Agreement</B>&rdquo;)
and (ii) that certain Placement Agency Agreement, dated as of October 22, 2025 by and between the Company and Northland Securities, Inc.
(the &ldquo;<B>Placement Agency Agreement</B>&rdquo;). The Shares will be offered and sold pursuant to the Company&rsquo;s shelf-registration
statement on Form S-3 under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), filed with the Securities
and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) on October 16, 2024 (Registration No. 333-282681) (the &ldquo;<B>Registration
Statement</B>&rdquo;), a base prospectus dated October 31, 2024 (the &ldquo;<B>Base Prospectus</B>&rdquo;) and the prospectus supplement
dated October 22, 2025, filed with the Commission pursuant to Rule 424(b) under the Securities Act (together with the Base Prospectus,
the &ldquo;<B>Prospectus</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is being furnished in accordance
with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have reviewed originals or copies of (a) the
Registration Statement, (b) the Prospectus, (c) an executed copy of the Subscription Agreement, (d) an executed copy of the Placement
Agency Agreement, (e) the certificate of incorporation and bylaws of the Company, as amended through the date hereof, and (f) certain
resolutions of the board of directors of the Company or committees thereof. We have also examined originals or copies, certified or otherwise
identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have
deemed necessary or advisable as a basis for the opinion set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In rendering the opinion set forth below, we have
assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all items submitted to us as originals,
the conformity with originals of all items submitted to us as copies, and the authenticity of the originals of such copies. As to any
facts material to the opinions expressed herein, we have relied upon statements and representations of officers and other representatives
of the Company and public officials. We have also assumed, with respect to the issuance of the Shares, the amount of valid consideration
paid in respect of such Shares will equal or exceed the par value of such Shares. We have not independently established the validity of
the foregoing assumptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is limited to the federal
laws of the United States of America, the laws of the State of New York and the Delaware General Corporation Law. We express no opinion,
and make no statement, as to the laws, rules, or regulations of any other jurisdiction or as to the municipal laws or the laws, rules,
or regulations of any local agencies or governmental authorities of or within the State of Delaware and New York, or as to any matters
arising thereunder or relating thereto. We do not find it necessary for the purposes of this opinion letter to cover, and accordingly
we express no opinion as to, the application of the securities or blue-sky laws of the various states to sales of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on, and subject to the foregoing and the
other limitations, qualifications, exceptions and assumptions set forth herein, we are of the opinion that the Shares have been duly authorized
and, when issued and delivered by the Company pursuant to the provisions of the Subscription Agreement and the Placement Agency Agreement
against payment of the requisite consideration therefor, will be validly issued, fully paid, and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinions set forth herein are given as of
the date hereof, and we undertake no obligation to update or supplement this opinion letter if any applicable law changes after the date
hereof or if we become aware of any fact or other circumstances that changes or may change our opinion set forth herein after the date
hereof or for any other reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">We consent
to the inclusion of this opinion letter as an exhibit to the Registration Statement and further consent to all references to us under
the caption &ldquo;Legal Matters&rdquo; in the Prospectus and to the filing of this opinion as an exhibit to the Company&rsquo;s Current
Report on Form 8-K, dated October 24, 2025. In giving this consent, we do not admit that we are in the category of persons whose consent
is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Reed Smith LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REED SMITH LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea026231501ex10-1_spectral.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED OCTOBER 22, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
Version</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of October 22, 2025, between Spectral AI, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities
Act (as defined below) as to the Shares (as defined below) and (ii) an exemption from the registration requirements of Section 5 of the
Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Pre-Funded Warrants, Common Warrants and
Warrant Shares (each as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1&nbsp;
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo; shall have the meaning ascribed
to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares, Pre-Funded Warrants and Common Warrants pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Shares, Pre-Funded Warrants and Common Warrants, in each case, have been satisfied or waived, but in no event
later than the first (1<SUP>st</SUP>) Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants to be delivered to the Purchasers at the Closing in accordance
with Section 2.2(a)(vii) hereof, which Warrants shall be exercisable at any time on or after the date that is the earlier of (i) the
Stockholder Approval Date and (ii) the date that is six months following the Closing Date, and have a term equal to five (5) years, in
the form of <U>Exhibit A-2</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Reed Smith LLP with offices located at 2850 N Harwood St Suite 1500, Dallas, TX 75201.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
shall have the meaning ascribed to such term in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure Time</U>&rdquo; means, if this Agreement is signed
on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day,
9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Environmental Laws</U>&rdquo; shall have the
meaning assigned to such term in Section 3.1(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(v).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange Act</U>&rdquo; means the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company; (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price, or conversion price of such securities or to extend the term of such securities (in each case, other than in connection with stock
splits, stock dividends, recapitalizations, reorganizations, reclassifications combinations, reverse stock splits, or other similar events
occurring after the date hereof); provided further, that it is understood that such securities will not be deemed to have been amended
if the terms of such securities are automatically changed in accordance with their terms as such terms exist on the date of this Agreement,
such as a decrease in their exercise price due to an anti-dilution provision; and (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith during the prohibition period in Section 4.12(a) herein, and provided that any such issuance shall only be to
a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset
in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo; shall have the meaning ascribed to such term in
Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Hazardous
Materials</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and directors, officers and stockholders
of the Company set forth on <U>Exhibit C</U> hereto, in the form of <U>Exhibit D</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Ontario
Inc.</U>&rdquo; means 1001304798 ONTARIO INC., a Canadian corporation and wholly-owned subsidiary of the Company, which was formed in
August, 2025 for the use of a new Canadian employee whom was not employed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $1.90, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Northland Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded Warrant Purchase Price</U>&rdquo; equals $1.8999.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with
Section 2.2(a)(vi) hereof, in the form of <U>Exhibit A-1</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Settlement
Period</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Settlement
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo; means an action, claim, suit, investigation or proceeding (including, without limitation, an
informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the base prospectus included in the Registration Statement, including all information, documents, and exhibits filed or incorporated
by reference into such prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act, including all information,
documents, and exhibits filed or incorporated by reference into such prospectus supplement, that will be filed with the Commission in
connection with the offer of the Shares, but not, for avoidance of doubt, the offer and sale of the Pre-Funded Warrants, the Common Warrants
or the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration Rights Agreement</U>&rdquo;
means the Registration Rights Agreement, dated on or about the date hereof, in the form attached hereto as <U>Exhibit B</U>,
pursuant to which the Company will agree to provide certain registration rights in respect of the Warrant Shares under the
Securities Act and applicable state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-282681 which registers the sale of the Shares
to the Purchasers, and includes any Rule 462(b) Registration Statement, but, for the avoidance of doubt, does not register the sale of
the Pre-Funded Warrants, Common Warrants or Warrant Shares to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or
interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same
purpose and effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
462(b) Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Public Securities,
which was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated
by the Commission pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo; means the Shares,
the Pre-Funded Warrants, the Common Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 39pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 39pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the rules and regulations of the applicable Trading Market from the stockholders
of the Company with respect to the issuance of all Warrant Shares, including after giving full effect to the adjustments in the Exercise
Price and/or number of shares of Common Stock underlying the Common Warrants in Section 3(b) of the Common Warrant following any Dilutive
Issuance (as such term is defined in the Common Warrant).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares, Pre-Funded Warrants and Warrants purchased
hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and Ontario Inc., and shall, where applicable, also include any direct
or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Pre-Funded Warrants, the Common Warrants, the Registration Rights Agreement, all exhibits
and schedules thereto and hereto and any other documents or agreements executed with the Purchasers in connection with the transactions
contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Co., the current transfer agent of the Company, with a mailing address
of 1 State Street, 30th Floor New York, NY 10004, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&nbsp;<U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally
and not jointly, agree to purchase, an aggregate of $7,600,000 of Shares, Pre-Funded Warrants and Warrants. On the Closing Date, each
Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be delivered by wire
transfer to a bank account designated by the Company. The Company shall deliver to each Purchaser its respective Shares, Pre-Funded Warrants
and Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in
Section 2.2 deliverable at the Closing. The Shares and Pre-Funded Warrants will be sold in fixed combinations with the Common Warrants,
with each Purchaser receiving a Warrant to purchase one share of Common Stock per each Share or Warrant Share underlying a Pre-Funded
Warrant purchased by such Purchaser. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing
shall occur at the offices of the Company or such other location as the parties shall mutually agree. On the Closing Date, the Company
shall issue the Shares in book entry form registered in the Purchasers&rsquo; names released by the Transfer Agent directly to the account(s)
identified by each Purchaser following receipt of payment therefor. The Company shall issue the Pre-Funded Warrants, if applicable, and
Warrants to each Purchaser in definitive form on the Closing Date. Notwithstanding anything herein to the contrary, if at any time on
or after the time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately
prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of the
Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser
shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally
bound to purchase, such Pre-Settlement Shares at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement
Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder; and provided
further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser
as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and that any
such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to effect any
such sale, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Registration Rights Agreement duly executed by the Company;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;a
legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, substantially in the form reasonably acceptable
to the Placement Agent and the Purchasers, as applicable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;subject
to Section 2.1, the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial
Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;subject
to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited
basis via The Depository Trust Company Deposit or Withdrawal at Custodian system Shares equal to any portion of such Purchaser&rsquo;s
Subscription Amount, at such Purchaser&rsquo;s election, divided by the Per Share Purchase Price (rounded down to the nearest whole share)
and registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&nbsp;subject
to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to the number of shares of Common Stock
equal to any remaining portion of such Purchaser&rsquo;s Subscription Amount which was not allocated to the purchase of Shares by such
Purchaser pursuant to Section 2.2(a)(v), divided by the Pre-Funded Warrant Purchase Price (rounded down to the nearest whole share),
with an exercise price equal to $0.0001 per share, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)&nbsp;subject
to Section 2.1, a Warrant registered in the name of such Purchaser to purchase up to the number of shares of Common Stock equal to 100%
of such Purchaser&rsquo;s Shares and Warrant Shares underlying Pre-Funded Warrants purchased by such Purchaser, with an exercise price
equal to $2.51 per share (the &ldquo;<U>Exercise Price</U>&rdquo;), subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on the date hereof, the duly executed Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)&nbsp;the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;the
Registration Rights Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;such
Purchaser&rsquo;s Subscription Amount, which shall be delivered by each such Purchaser to the Company at the bank account designated
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing Conditions</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as
of a specific date therein in which case they shall be accurate (or, to the extent representations or warranties are qualified by materiality
or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate in all material respects (or to the extent
representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;there
shall have been no Material Adverse Effect with respect to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Shares, Pre-Funded Warrants and Warrants at the Closing.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1&nbsp;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports, other than Ontario Inc. Except as set forth
in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free
and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted and as described in the SEC Reports. Neither
the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and
is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be,
would not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any
Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability
to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities (including the issuance of Warrant Shares upon the exercise of the Pre-Funded
Warrants and Common Warrants) and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i)
conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the
Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other
instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a
party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required
Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state
securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in
the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required
pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) filings made pursuant
to the Registration Rights Agreement, (iv) notice and/or application(s) to each applicable Trading Market for the listing of the Shares
and Warrant Shares for trading thereon in the time and manner required thereby, (v) such filings as are required to be made under applicable
state securities laws and/or the rules of the Financial Industry Regulatory Authority, Inc. and (vi) the Stockholder Approval (collectively,
the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Issuance
of the Securities; Registration</U>. The Shares, Pre-Funded Warrants and Common Warrants are duly authorized and, when issued and
paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Warrant Shares are duly authorized, and when issued and paid for in
accordance with the terms of the Pre-Funded Warrants and Common Warrants, as applicable, will be validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company. The Company will have reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to the Pre-Funded Warrants and the Common Warrants. The Company
has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective
on October 31, 2024, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of
this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the
effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission
and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The
Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule
424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the
Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the
requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any
amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing
Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain
an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration
Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction
requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve
(12) months prior to this offering, as set forth in General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<U>Capitalization</U>.
The Company has an authorized and outstanding capitalization as set forth in Schedule 3.1(g), which also includes the number of
shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date of this Agreement. The Company
has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the
exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans, pursuant to the conversion and/or exercise of Common Stock
Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of
first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the
Transaction Documents that has not been waived in writing. Except as set forth on Schedule 3.1(g), there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any
shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or
capital stock of any Subsidiary. The issuance and sale of the Securities (including the issuance of the Warrant Shares upon exercise
of the Pre-Funded Warrants and Common Warrants) will not obligate the Company or any Subsidiary to issue shares of Common Stock or
other securities to any Person (other than the Purchasers). Except as set forth on Schedule 3.1(g), there are no outstanding
securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or
reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a
security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo;
plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly
authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase
securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance
and sale of the Securities. Other than this Agreement and the Registration Rights Agreement, there are no stockholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or,
to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) and, during the past twelve
(12) calendar months, such SEC Reports have been filed on a timely basis or the Company has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports
complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading (it
being understood that such disclosure furnished by or on behalf of the Company to the Purchasers includes the SEC Reports). The Company
has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC
Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the most recent unaudited financial statements
included within the SEC Reports, except as disclosed in the SEC Reports, (i) there has been no event, occurrence or development that
has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any
liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant
to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting in any material
manner, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or
purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued
any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company
does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the
Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses,
prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one
Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;<U>Litigation</U>.
Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;) which (i) adversely affects or challenges the legality, validity or enforceability of
any of the Transaction Documents or the Securities or (ii) would, if there were an unfavorable decision, have or reasonably be expected
to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the
subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission
involving the Company or to the Company&rsquo;s knowledge any current or former director or officer of the Company. The Commission has
not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&nbsp;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their
relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as would not have or reasonably be expected to result in a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&nbsp;<U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and
good and marketable title in all personal property owned by them that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and
(ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under
lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and
the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or except as would not have a Material Adverse Effect is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the most
recent unaudited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that
the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no material existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have
taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)&nbsp;<U>Open
Source Software</U>. (i) To the best of the Company&rsquo;s knowledge, the Company uses and has used any and all software and other materials
distributed under a &ldquo;free,&rdquo; &ldquo;open source,&rdquo; or similar licensing model (including but not limited to the MIT License,
Apache License, GNU General Public License, GNU Lesser General Public License and GNU Affero General Public License) (&ldquo;<U>Open
Source Software</U>&rdquo;) in compliance with all license terms applicable to such Open Source Software; and (ii) the Company has not
used or distributed and does not use or distribute any Open Source Software in any manner that requires or has required (A) the Company
to permit reverse engineering of any software code or other technology owned by the Company or (B) any software code or other technology
owned by the Company to be (1) disclosed or distributed in source code form, (2) licensed for the purpose of making derivative works
or (3) redistributed at no charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)&nbsp;<U>Data
Security</U>. (i) To the Company&rsquo;s knowledge, the Company has complied and is presently in compliance with all internal and
external privacy policies, contractual obligations, applicable laws, statutes, judgments, orders, rules and regulations of any court
or arbitrator or other governmental or regulatory authority and any other legal obligations, in each case, relating to the
collection, use, transfer, import, export, storage, protection, disposal and disclosure by the Company of personal, personally
identifiable, household, sensitive, confidential or regulated data (&ldquo;<U>Data Security Obligations</U>,&rdquo; and such data,
&ldquo;<U>Data</U>&rdquo;); (ii) the Company has not received any notification of or complaint regarding and is unaware of any other
facts that, individually or in the aggregate, would reasonably indicate non-compliance with any Data Security Obligation; and (iii)
there is no action, suit or proceeding by or before any court or governmental agency, authority or body pending or threatened
alleging non-compliance with any Data Security Obligation nor are there any incidents under internal review or investigations
relating to the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)&nbsp;<U>Data
Protection; No Breaches</U>. To the Company&rsquo;s knowledge, the Company&rsquo;s information technology assets and equipment, computers,
systems, networks, hardware, software, websites, applications, and databases are adequate for, and operate and perform in all material
respects as required in connection with, the operation of the business of the Company as currently conducted. The Company has taken commercially
reasonable efforts to protect the information technology systems and Data used in connection with the operation of the Company&rsquo;s
business. Without limiting the foregoing, the Company has used reasonable efforts to establish and maintain reasonable information technology,
information security, cyber security and data protection controls, policies and procedures, including oversight, access controls, encryption,
technological and physical safeguards and business continuity/disaster recovery and security plans that are designed to protect against
and prevent breach, destruction, loss, unauthorized distribution, use, access, disablement, misappropriation or modification, or other
compromise or misuse of or relating to any information technology system or Data used in connection with the operation of the Company&rsquo;s
business (&ldquo;<U>Breach</U>&rdquo;). There has been no such Breach, and the Company has not been notified of and has no knowledge
of any event or condition that would reasonably be expected to result in, any such Breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)&nbsp;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. Although the Company is a public reporting company, it qualifies as a non-accelerated filer/emerging
growth company/smaller reporting company and is therefore not currently subject to certain compliance requirements under the Sarbanes-Oxley
Act of 2002. When applicable, the Company anticipates it and the Subsidiaries shall be compliant in all material respects with any and
all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date thereof, and any and all
applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date thereof. The Company and
the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the
Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the
disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed
periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently
filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls
and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal
control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)&nbsp;<U>Certain
Fees</U>. Except for (i) fees payable by the Company to the Placement Agent and (ii) warrants being issued by the Company pursuant to
that certain Confirmation Agreement, dated as of October 14, 2025 between Spectral AI, Inc. and Dominari Securities, LLC (the &ldquo;<U>Confirmation
Agreement&rdquo;)</U>, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to
any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares and Pre-Funded
Warrants and Common Warrants, will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the
Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an
&ldquo;investment company&rdquo; subject to registration under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)&nbsp;<U>Registration
Rights</U>. Except as set forth on Schedule 3.1(y), and in the Registration Rights Agreement, no Person has any right to cause the Company
or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary. Except for
the rights pursuant to the Confirmation Agreement, no person has &ldquo;piggy-back&rdquo; registration rights that would pre-empt or
&ldquo;cut-back&rdquo; the registration rights granted to the Purchasers under the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)&nbsp;<U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken
no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under
the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. The
Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or
has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading
Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all
such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust
Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel
with any information that it believes constitutes or might constitute material, non-public information which is not otherwise
disclosed in the Prospectus or Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the
foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of
the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules, is true and correct and does not contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the
date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any
representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in
Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the
Common Warrants, the Pre-Funded Warrants or the Warrant Shares under the Securities Act or (ii) any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the date hereof, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) <U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to
be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Accountants</U>. The Company&rsquo;s accounting firm is Forvis Mazars, LLP. To the knowledge and belief of the Company, such accounting
firm is a registered public accounting firm as required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives. The Company has not relied upon the Placement Agent or any of
its Affiliates or representatives for any legal, tax or accounting advice in connection with the offering and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.16 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the
Securities (except in accordance with applicable securities laws) for any specified term; (ii) past or future open market or other
transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the
Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to
which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock,
and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any
&ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in
hedging activities at various times during the period that the Securities are outstanding, and (z) such hedging activities (if any)
could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of
any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer,
agent, employee or affiliate of the Company or any Subsidiary is currently subject to any sanctions administered or enforced by the U.S.
Government, including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;<U>OFAC</U>&rdquo;)
or the U.S. Department of State and including, without limitation, the designation as a &ldquo;specially designated national&rdquo; or
&ldquo;blocked person&rdquo; (&ldquo;<U>Sanctions</U>&rdquo;). Since April 24, 2019, the Company nor any of its Subsidiaries have knowingly
engaged in or are now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction
is or was the subject or the target of Sanctions or with any Sanctioned Country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Pre-Funded Warrants, the Common Warrants or the Warrant
Shares by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene
the rules and regulations of the Trading Market (including the issuance of Warrant Shares upon exercise of the Common Warrants and Pre-Funded
Warrants).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Pre-Funded
Warrants, Common Warrants or Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Pre-Funded
Warrants, Common Warrants and Warrant Shares for sale only to the Purchasers and certain other institutional &ldquo;accredited investors&rdquo;
within the meaning of Rule 501 under the Securities Act and/or &ldquo;qualified institutional buyers&rdquo; within the meaning of Rule
144A under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2&nbsp;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized
by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.
Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it
in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and not with a view to or for distributing
or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law. Such Purchaser
has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities
(this representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement,
if applicable, or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities
hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Restricted
Securities</U>. Such Purchaser understands that the Pre-Funded Warrants, the Common Warrants and the Warrant Shares are &ldquo;restricted
securities&rdquo; and have not been registered under the Securities Act or any applicable state securities law in reliance on the availability
of an exemption from such registration and that under such laws and applicable regulations such securities may be resold without registration
under the Securities Act only in certain limited circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises the Pre-Funded Warrants and the Common Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), or (a)(9) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo;
as defined in Rule 144A(a) under the Securities Act. Such investor is a sophisticated investor, with sufficient knowledge and experience
in investing in private equity transactions to properly evaluate the risks and merits of its purchase of the Pre-Funded Warrants, Common
Warrants and Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all
exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has
deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering
of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its
financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its
investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without
unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such
Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate or representative of the Placement Agent has
provided such Purchaser with any information or advice with respect to the Company or the Securities nor is such information or
advice necessary or desired. Neither the Placement Agent nor any Affiliate or representative of the Placement Agent has made or
makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate or
representative of the Placement Agent may have acquired non-public information with respect to the Company which such Purchaser
agrees need not be provided to it. In connection with the issuance of the Shares to such Purchaser, neither the Placement Agent nor
any of its Affiliates or representatives have acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;<U>No
General Solicitation</U>. Such Purchaser did not learn of the investment in the Securities as a result of any general or public solicitation
or general advertising, or publicly disseminated advertisements or sales literature, including, without limitation, (i) any advertisement,
article, notice or other communication published in any newspaper, magazine, website, or similar media, or broadcast over television
or radio, or (ii) any seminar or meeting to which such Purchaser was invited by any of the foregoing means of communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>Legends</U>.
It is understood that, except as provided below, and subject to Section 4.2, certificates or book-entry records evidencing the Pre-Funded
Warrants, Common Warrants and Warrant Shares may bear the following or any similar legend:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;NEITHER
                                            THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED
                                            WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
                                            RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
                                            (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
                                            TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
                                            EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
                                            SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD STYLE="padding-left: 0pt; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            required by the authorities of any state in connection with the issuance or sale of the Pre-Funded
                                            Warrants, Common Warrants and Warrant Shares, the legend required by such state authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;For
the avoidance of doubt, certificates or book-entry records evidencing Warrant Shares shall not contain any legend (including the legend
set forth above) while a registration statement covering the resale of such security is effective under the Securities Act. <U>Residency</U>.
Such Purchaser&rsquo;s office in which its investment decision with respect to the Securities was made is located at the address immediately
below such Purchaser&rsquo;s name on its signature page hereto, except as otherwise communicated in writing by such Purchaser to the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1&nbsp;<U>Furnishing
of Information</U>. Until the time that no Purchaser owns Shares, the Company covenants to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Removal of Legends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;The
Pre-Funded Warrants, Common Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities laws.
In connection with any sale, assignment, transfer or other disposition of the Warrant Shares by a Purchaser pursuant to Rule 144 or pursuant
to any other exemption under the Securities Act such that the purchaser acquires freely tradable shares and upon compliance by the Purchaser
with the requirements of this Agreement, if requested by the Purchaser, the Company shall request the Transfer Agent to remove any restrictive
legends related to the book entry account holding such Warrant Shares and to make a new, unlegended entry for such book entry shares
sold or disposed of without restrictive legends within one (1) Trading Day of any such request therefor from such Purchaser, provided
that the Company has timely received from such Purchaser customary representations and other documentation reasonably acceptable to the
Company in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;Subject
to receipt from the Purchaser by the Company and the Transfer Agent of customary representations and other documentation reasonably acceptable
to the Company and the Transfer Agent in connection therewith, upon the earliest of such time as the Warrant Shares (i) have been registered
under the Securities Act pursuant to an effective registration statement, (ii) have been sold pursuant to Rule 144, or (iii) are eligible
for resale under Rule 144(b)(1) without the requirement for the Company to be in compliance with the current public information requirements
under Rule 144(c)(1) (or any successor thereto), the Company shall, in accordance with the provisions of this Section 4.2(b) and within
one (1) Trading Day of any request therefor from a Purchaser accompanied by such customary and reasonably acceptable documentation referred
to above, (A) deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall make a new, unlegended entry for such
book entry Warrant Shares, and (B) cause its counsel to deliver to the Transfer Agent one or more opinions to the effect that the removal
of such legends in such circumstances may be effected under the Securities Act if required by the Transfer Agent to effect the removal
of the legend in accordance with the provisions of this Agreement. The Company agrees that following the time as such legend is no longer
required under this Section 4.2, it will, within one (1) Trading Day of the delivery by a Purchaser to the Company or the Transfer Agent
of a certificate representing shares issued with a restrictive legend and receipt from the Purchaser by the Company and the Transfer
Agent of customary representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection
therewith, deliver or cause to be delivered to such Purchaser a certificate representing such Warrant Shares (or uncertificated interest
therein) that is free from all restrictive and other legends. Warrant Shares subject to legend removal hereunder may be transmitted by
the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the DTC System as directed by
such Purchaser. The Company shall be responsible for the fees of its Transfer Agent and all DTC fees associated with such issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company (i) that such Purchaser will sell any
Warrant Shares only pursuant to either the registration requirements of the Securities Act, including any applicable prospectus
delivery requirements, or an exemption therefrom, (ii) that if Warrant Shares are sold pursuant to a registration statement, they
will be sold in compliance with the plan of distribution set forth therein and (iii) that if, after the effective date of the
registration statement covering the resale of the Warrant Shares (the &ldquo;<U>Effective Date</U>&rdquo;), such registration
statement ceases to be effective and the Company has provided notice to such Purchaser to that effect, such Purchaser will sell
Warrant Shares only in compliance with an exemption from the registration requirements of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3&nbsp;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the
registration under the Securities Act of the sale of the Pre-Funded Warrants, Common Warrants or Warrant Shares to the Purchasers or
that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such
that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before
the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4&nbsp;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of
the transactions contemplated hereby and any other nonpublic information that the Company has provided to the Purchasers, and (b) file
a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by
the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly
disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, in connection
with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the
Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral,
between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees, Affiliates or agents,
including without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other
hand, shall terminate and be of no further force or effect. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each
other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser
shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect
to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company,
which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing
party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5&nbsp;<U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6&nbsp;<U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, employees or Affiliates delivers any material, non-public information
to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any
duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective
officers, directors, employees, Affiliates or agents including, without limitation, the Placement Agent, not to trade on the basis of,
such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7&nbsp;<U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Shares, Pre-Funded Warrants and Common Warrants
hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the
Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior
practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding
litigation or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8&nbsp;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its
directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such
Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser
Party</U>&rdquo;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation
that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action
instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the
Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction
Documents, unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations, warranties or
covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party
which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own
choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such
Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of Company counsel a material conflict on any material issue between the position of the Company
and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no
more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any
settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld
or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this
Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The
indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against
the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9&nbsp;<U>Exculpation
of Placement Agent</U>. Each party hereto agrees for the express benefit of the Placement Agent and its affiliates and representatives
that the Placement Agent and its affiliates and representatives (i) shall not be liable for any improper payment made in accordance with
the information provided by the Company; (ii) make no representation or warranty, and have no responsibilities as to the validity, accuracy,
value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company pursuant to this Agreement
or in connection with any of the transactions contemplated hereby, including any offering or marketing materials; and (iii) shall not
be liable (A) for any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within
the discretion or rights or powers conferred upon them by this Agreement or any Transaction Document, or (B) for anything which any of
them may do or refrain from doing in connection with this Agreement or any Transaction Document, except in each case for such person&rsquo;s
own gross negligence, willful misconduct or bad faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10&nbsp;<U>Listing
of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and the Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and the Warrant
Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading
Market, it will then include in such application all of the Shares and the Warrant Shares, and will take such other action as is necessary
to cause all of the Shares and the Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to use commercially reasonable efforts to maintain the eligibility of the Common Stock for electronic transfer through
the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to
the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11&nbsp;<U>Reservation
of Common Stock</U>. The shares of Common Stock issuable upon exercise of the Warrants and the Pre-Funded Warrants shall be duly authorized
and reserved for issuance for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant
to any exercise of the Pre-Funded Warrants and Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent Equity Sales</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;From
the date hereof until 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration
statement or amendment or supplement thereto, other than the Prospectus Supplement and registration statement to be filed pursuant to
the Registration Rights Agreement to cover the Warrant Shares and shares issuable upon exercise of warrants issued to Dominari Securities,
LLC under the Confirmation Agreement, and the Warrant Shares and shares issuable upon exercise of warrants issued to Avenue Capital,
pursuant to that certain Warrant Agreement, dated March 21, 2025 between the Company and Avenue Capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;From
the date hereof until two (2) years after the Effective Date, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a
transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price
or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common
Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price
that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock
or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an
&ldquo;at-the-market offering&rdquo; as defined in Rule 415(a)(4) under the Securities Act, whereby the Company may issue securities
at a future determined price whereby the Company may issue securities at a future determined price regardless of whether shares
pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled; provided
however, that (i) after the date that is six months after the Closing Date, the entry into and/or issuance of shares of Common Stock
in an &ldquo;at-the-market&rdquo; offering as defined in Rule 415(a)(4) under the Securities Act and (ii) securities issued to
Avenue Capital pursuant to the terms of the Company&rsquo;s existing Loan and Security Agreement dated as of March 21, 2025,
provided further that such securities have not been amended since the Effective Date to increase the number of such securities or to
decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock dividends,
stock splits or combinations) or to extend the term of such securities, shall not be deemed a Variable Rate Transaction. Any
Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in
addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Notwithstanding
the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be
an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13&nbsp;<U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to such Transaction Document. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14&nbsp;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such
time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction (other than as
disclosed to its legal and other representatives). Notwithstanding the foregoing, and notwithstanding anything contained in this
Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or
covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in
Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in
accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first
publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of
confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their
respective officers, directors, employees, Affiliates or agent, including without limitation, the Placement Agent, after the
issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is
a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and
the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the
portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15&nbsp;<U>Capital
Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or
reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares
(based on the initial Subscription Amounts hereunder) other than a reverse stock split that is required, in the good faith determination
of the Board of Directors, to maintain the listing of the Common Stock on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16&nbsp;<U>Lock-Up
Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend
the term of the lock-up period, and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party
to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use commercially reasonable efforts
to seek specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17&nbsp;<U>Stockholder
Approval</U>. At the Company&rsquo;s next meeting of stockholders, the Company shall seek Stockholder Approval, with the recommendation
of the Board of Directors that such proposal be approved, and the Company shall solicit proxies from its stockholders in connection therewith
in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their
proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain such Stockholder Approval. If the Company
is unable to secure Stockholder Approval by June 1, 2026, the Company shall convene subsequent stockholder meetings no less frequently
than once every 90 days until such time as the Stockholder Approval is obtained or the Common Warrants are no longer outstanding.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1&nbsp;<U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect
whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing
has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2&nbsp;<U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Shares to the Purchaser, as well
as the fees and expenses of the Placement Agent as set forth in the Placement Agency Agreement, by and between the Company and the Placement
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3&nbsp;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York
City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or
later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of
mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice
is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5&nbsp;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and Purchasers which purchased at least 50% in interest of the Shares based on the
initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by
the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a
waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right
hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially
and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other
Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company. Notwithstanding the foregoing or
anything else herein to the contrary, no amendment, modification, alteration, change or waiver of Sections 4.10 and 5.8 and this
sentence in Section 5.5 shall be valid without the prior written consent of the Placement Agent, which consent may be granted or
withheld in the reasonable discretion of such Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6&nbsp;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8&nbsp;<U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be third-party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns, and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be
governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or
Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is
improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under
Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or
Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10&nbsp;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11&nbsp;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file or any electronic signature complying with the U.S. federal ESIGN Act of 2000, the Uniform Electronic Transactions Act
or other applicable law (e.g., www.docusign.com), such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; or &ldquo;electronic&rdquo;
signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13&nbsp;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights; provided, however, that, in the case of a rescission of an exercise
of a Pre-Funded Warrant or Common Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to
any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company
for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded
Warrant or Common Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14&nbsp;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15&nbsp;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16&nbsp;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17&nbsp;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel may choose to communicate with the Company through
the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only
represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood
and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser,
solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18&nbsp;<U>Saturdays,
Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19&nbsp;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.20&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>SPECTRAL AI, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt; width: 6%">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt; width: 30%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt; width: 40%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">2515 McKinney Ave., Suite 1000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">J. Michael DiMaio, MD</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Dallas, Texas 75201</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Chairman of the Board of Directors</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">E-Mail: vcapone@spectral-ai.com</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Reed Smith LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">2850 N. Harwood Street, Suite 1500</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Dallas, TX 75201</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Attention: Lynwood E. Reinhardt Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">lreinhardt@reedsmith.com</FONT> &nbsp; &nbsp; &nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Signature Page to Securities Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: _______________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: </FONT>_________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory:_______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile
Number of Authorized Signatory:____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Shares to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $ ________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
<U>&#9;</U>____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Pre-Funded Warrant Shares: ____________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Common Warrant Shares: ____________ Beneficial Ownership Blocker&nbsp;&#9744;&nbsp;4.99% or&nbsp;&#9744;&nbsp;  9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ___</FONT>_____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of
the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded,
(ii) the Closing shall occur on the first (1<SUP>st</SUP>) Trading Day following the date of this Agreement and (iii) any condition
to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company
or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a
condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such
agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Signature Page to Securities
Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A-1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Pre-Funded Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A-2</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Common Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Registration Rights Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Erich Spangenberg</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J. Michael DiMaio, MD</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Richard Cotton</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Martin Mellish</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. Colin Bristow</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. Marion Snyder</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. Deepak Sadagopan</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. Vincent Capone</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. Stan Micek</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. Jeremiah Sparks</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
D</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Lock-Up Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October___, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Northland
Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150
South Fifth Street, Ste. 3300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
MN 55402</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spectral
AI, Inc. | Registered Direct Offering</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that you, as the placement agent (the &ldquo;<I>Placement Agent</I>&rdquo;), propose to enter into a placement
agency agreement (the &ldquo;<I>Placement Agency Agreement</I>&rdquo;), as Placement Agent, with Spectral AI, Inc., a Delaware corporation
(the &ldquo;<I>Company</I>&rdquo;), and Securities Purchase Agreement with the purchasers identified on the signature page thereto (the
&ldquo;<I>SPA</I>&rdquo;) providing for the offer and sale (the &ldquo;<I>Offering</I>&rdquo;) of securities of the Company (the &ldquo;<I>Securities</I>&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Placement Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Lock-Up</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the Placement Agent&rsquo;s agreement to act as Placement Agent for the Offering of the Securities, and for other good
and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent
of the Placement Agent, the undersigned will not, and will not cause any direct or indirect affiliate to, during the period beginning
on the date of the final prospectus supplement relating to the Offering (the &ldquo;<I>Prospectus</I>&rdquo;) and ending at the close
of business on the date that is 90 days after the Effective Date (such period, the &ldquo;<I>Restricted Period</I>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right
or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock, par value $0.0001
per share, of the Company (the &ldquo;<I>Common Stock</I>&rdquo;) or any securities convertible into or exercisable or exchangeable for
Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the
undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued
upon exercise of a stock option or warrant) (collectively with the Common Stock, the &ldquo;<I>Lock-Up Securities</I>&rdquo;),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;enter
into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership
of the Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up
Securities, in cash or otherwise,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;make
any demand for or exercise any right with respect to the registration of any Lock-Up Securities, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">publicly disclose the intention to do any of the foregoing.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions
or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or
combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or
intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the
undersigned or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any
Lock-Up Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery
of Lock-Up Securities, in cash or otherwise. The undersigned further confirms that it has furnished the Placement Agent with the
details of any transaction the undersigned, or any of its affiliates, is a party to as of the date hereof, which transaction would
have been restricted by this Letter Agreement (this &ldquo;<I>Letter Agreement</I>&rdquo;) if it had been entered into by the
undersigned during the Restricted Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Lock-Up
Exceptions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the undersigned may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transfer or dispose of the undersigned&rsquo;s Lock-Up Securities:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as a bona fide gift or gifts, or for bona fide estate planning purposes,</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by will or intestacy,</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;to
any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned is
a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement,
&ldquo;immediate family&rdquo; shall mean any relationship by blood, current or former marriage, domestic partnership or adoption, not
more remote than first cousin),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;to
a corporation, partnership, limited liability company or other entity of which the undersigned or the immediate family of the undersigned
are the legal and beneficial owner of all of the outstanding equity securities or similar interests,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;to
a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&nbsp;if
the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation,
partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under
the Securities Act of 1933, as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing
or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where
the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership),
or (B) as part of a distribution to members, partners, shareholders or other equity holders of the undersigned,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)&nbsp;by
operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or related
court order,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)&nbsp;to
the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such employee,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)&nbsp;as
part of a sale of the undersigned&rsquo;s Lock-Up Securities acquired in open market transactions after the completion of the Offering,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&nbsp;to
the Company in connection with the vesting, settlement, exchange, conversion or exercise of restricted stock units, options,
warrants or other rights to purchase shares of Common Stock (including, in each case, by way of &ldquo;net&rdquo; or
&ldquo;cashless&rdquo; exercise), including for the payment of exercise price and tax and remittance payments due as a result of the
vesting, settlement, or exercise of such restricted stock units, options, warrants or rights, provided that any such shares of
Common Stock received upon such exercise, vesting or settlement (other than such shares as are transferred or surrendered to the
Company in connection with such vesting, settlement or exercise event) shall be subject to the terms of this Letter Agreement, and
provided further that any such restricted stock units, options, warrants or rights are held by the undersigned pursuant to an
agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is
described in the Registration Statement, the Incorporated Documents, the Base Prospectus and the Final Prospectus, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)&nbsp;pursuant
to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors
of the Company and made to all holders of the Company&rsquo;s capital stock involving a Change of Control1 of the Company; provided that
in the event that such tender offer, merger, consolidation or other similar transaction is not completed, the undersigned&rsquo;s Lock-Up
Securities shall remain subject to the provisions of this Letter Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, notwithstanding anything herein to the contrary, the undersigned may, without the consent of the Placement Agent, (i)
establish a trading plan under Rule 10b5-1 under the Exchange Act (a &ldquo;<I>10b5-1 Trading Plan</I>&rdquo;) or amend an existing
10b5-1 Trading Plan so long as there are no sales of Common Stock of the Company or derivative instruments under such plan during
the Restricted Period; <U>provided</U> that, the establishment of a 10b5-1 Trading Plan or the amendment of a 10b5-1 Trading Plan,
in either case, providing for sales of shares of Common Stock of the Company or any derivative instrument shall only be permitted if
(1) the establishment or amendment of such plan is not required to be reported during the Restricted Period in any public report or
filing with the SEC, or otherwise, and (2) the undersigned does not otherwise voluntarily effect any public filing or report
regarding the establishment or amendment of such plan, and (ii) transfer shares of Common Stock of the Company pursuant to a 10b5-1
Trading Plan in effect as of the date hereof which has been provided to the Placement Agent or their legal counsel, provided that
any filing required under Section 16 of the Exchange Act during the Restricted Period shall clearly indicate in the footnotes
thereto that the filing relates to a transaction pursuant to a 10b5-1 Trading Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the undersigned may, without the consent of Placement Agent, sell shares of Common Stock of the Company purchased by the undersigned
in the Offering or on the open market following the Offering if and only if (i) such sales are not required to be reported in any public
report or filing with the SEC, or otherwise, during the Restricted Period and (ii) the undersigned does not otherwise voluntarily effect
any public filing or report regarding such sales during the Restricted Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U>
that</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv) ,(v) and (vi), such transfer shall not involve
a disposition for value,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Change
of Control</I>&rdquo; shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction
or a series of related transactions, to a person or group of affiliated persons (other than the Placement Agent pursuant to the Offering),
of shares of capital stock if, after such transfer, such person or group of affiliated persons would hold more than 50% of the outstanding
voting securities of the Company (or the surviving entity).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="padding-left: 0pt; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v),
                                            (vi) and (vii), each donee, devisee, transferee or distributee shall execute and deliver
                                            to the Placement Agent a lock-up letter in the form of this Letter Agreement,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 0pt; text-align: justify; width: 0.75in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; text-align: justify; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="padding-left: 0pt; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of any transfer or distribution pursuant to clause (a)(ii), (iii), (iv), (v) and
                                            (vi), no filing by any party (donor, donee, devisee, transferor, transferee, distributer
                                            or distributee) under the Exchange Act, or other public announcement reporting a reduction
                                            in beneficial ownership of shares of Common Stock shall be required or shall be made voluntarily
                                            in connection with such transfer or distribution (other than a filing on a Form 5 made after
                                            the expiration of the Restricted Period referred to above), and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="padding-right: 0pt; text-align: justify; width: 0.75in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; width: 0.5in; text-align: justify; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT></TD><TD STYLE="padding-right: 0pt; text-align: justify; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
the case of any transfer or distribution pursuant to clauses (a)(i), (vii), (viii) and (x) it shall be a condition to such transfer that
no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange Act, or other
public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock in connection with such
transfer or distribution shall be legally required during the Restricted Period, such filing, report or announcement shall clearly indicate
in the footnotes thereto the nature and conditions of such transfer;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;exercise
outstanding options, settle restricted stock units or other equity awards or exercise outstanding warrants pursuant to plans described
in the Registration Statement, the Incorporated Documents, the Base Prospectus and the Final Prospectus; provided that any Lock-up Securities
received upon such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement; <U>provided</U> that if the
undersigned is required to make any filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement during
the Restricted Period, the undersigned shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described
in this clause and that the shares of Common Stock received upon the exercise or settlement, as applicable, of the stock option, warrant
or restricted stock unit or other right or vesting event are subject to this Letter Agreement, and no public filing, report or announcement
shall be voluntarily made; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;establish
trading plans pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities (each such plan, a &ldquo;<I>Trading
Plan</I>&rdquo;); provided that such Trading Plans do not provide for the transfer of Lock-Up Securities during the Restricted Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Beneficial
Ownership</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is not a natural person, the undersigned represents and warrants that no single natural person, entity or &ldquo;group&rdquo;
(within the meaning of Section 13(d)(3) of the Exchange Act) other than a natural person, entity or &ldquo;group&rdquo; (as described
above) that has executed a Letter Agreement in substantially the same form as this Letter Agreement, beneficially owns, directly or indirectly,
50% or more of the common equity interests, or 50% or more of the voting power, in the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Transfer
Agent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described
herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of
this Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Power
and Authority</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement.
All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the
successors, assigns, heirs or personal representatives of the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>No
Placement Agent Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned acknowledges and agrees that the Placement Agent has not provided any recommendation or investment advice nor has the Placement
Agent solicited any action from the undersigned with respect to the Offering of the Securities and the undersigned has consulted its
own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges
and agrees that, although the Placement Agent may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures
to you in connection with the Offering, the Placement Agent is not making a recommendation to you to enter into this Letter Agreement,
and nothing set forth in such disclosures is intended to suggest that the Placement Agent is making such a recommendation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Term
and Termination</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, (i) if the Placement Agency Agreement does not become effective by October 31, 2025, (ii) if the
Placement Agency Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to
payment for and delivery of the Common Stock to be sold thereunder, (iii) the Company notifies the Placement Agent in writing prior
to the execution of the Placement Agency Agreement that it does not intend to proceed with the Offering, or (iv) prior to payment
for the Securities, the Registration Statement is withdrawn prior to the execution of the Placement Agency Agreement, this Letter
Agreement shall automatically terminate and be of no further force or effect and undersigned shall be released from all obligations
under this Letter Agreement. The undersigned understands that the Placement Agent is entering into the Placement Agency Agreement
and proceeding with the Offering in reliance upon this Letter Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Miscellaneous</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby consents to receipt of this Letter Agreement in electronic form and understands and agrees that this Letter Agreement
may be signed electronically. In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by
electronic transmission (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com)
evidencing an intent to sign this Letter Agreement, such facsimile transmission, electronic mail or other electronic transmission shall
create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution
and delivery of this Letter Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and
binding for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of page left blank intentionally | signature page follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 24.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 24.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed
in accordance with the laws of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Security Holder <I>(Print exact name)</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If not signing in an individual capacity:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory <I>(Print)</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory <I>(Print)</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 50; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ea026231501ex10-2_spectral.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED OCTOBER 22, 2025, BY AND BETWEEN SPECTRAL AI, INC. AND NORTHLAND SECURITIES, INC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
Version</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLACEMENT
AGENCY AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
22, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NORTHLAND
SECURITIES, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150
South Fifth Street, Suite 3300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis,
MN 55402</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B>.
Subject to the terms and conditions herein (this &ldquo;<U>Agreement</U>&rdquo;), Spectral AI, Inc. a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
hereby agrees to sell up to an aggregate of approximately $7.6 million of registered and unregistered securities of the Company, including,
but not limited to, (i) an aggregate of 3,065,000 shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, $0.0001
par value per share (the &ldquo;<U>Common Stock</U>&rdquo;), (ii) unregistered pre-funded warrants to purchase up to an aggregate of
935,000 shares of Common Stock (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo; and the shares of Common Stock issuable upon exercise of
the Pre-Funded Warrants, the &ldquo;<U>Pre-Funded Warrant Shares</U>&rdquo;) at an exercise price of $0.0001 per share, and (iii) unregistered
Common Stock purchase warrants to purchase up to an aggregate of 4,000,000 shares of Common Stock (the &ldquo;<U>Common Warrants</U>&rdquo;
and the shares of Common Stock issuable upon exercise of the Common Warrants, the &ldquo;<U>Common Warrant Shares</U>&rdquo;), directly
to various investors (each, an &ldquo;<U>Investor</U>&rdquo; and, collectively, the &ldquo;<U>Investors</U>&rdquo;) through Northland
Securities, Inc. (the &ldquo;<U>Placement Agent</U>&rdquo;) as placement agent. The Shares, the Pre-Funded Warrants and the Common Warrants
sold to the Investors are referred to herein as the &ldquo;<U>Securities</U>.&rdquo; The documents executed and delivered by the Company
and the Investors in connection with the Offering (as defined below), including, without limitation, a securities purchase agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), shall be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo;
The purchase price to the Investors for each Share is $1.90. The Placement Agent may retain other brokers or dealers to act as sub-agents
or selected dealers on its behalf in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby confirms its agreement with the Placement Agent as follows:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.&nbsp;Agreement to Act as Placement Agent<FONT STYLE="font-weight: normal">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;On
the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering and sale by the Company
of the Shares pursuant to the Company&rsquo;s registration statement on Form S-3 (File No. 333-282681) (the &ldquo;<U>Registration Statement</U>&rdquo;),
with a concurrent private placement of the Pre-Funded Warrants and Common Warrants, with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;)
to be subject to market conditions and negotiations between the Company, the Placement Agent and the prospective Investors. The Placement
Agent will act on a reasonable best efforts basis and the Company agrees and acknowledges that there is no guarantee of the successful
placement of the Securities, or any portion thereof, in the prospective Offering. Under no circumstances will the Placement Agent or
any of its &ldquo;Affiliates&rdquo; (as defined below) be obligated to underwrite or purchase any of the Securities for its own account
or otherwise provide any financing. The Placement Agent shall act solely as the Company&rsquo;s agent and not as principal. The Placement
Agent shall have no authority to bind the Company with respect to any prospective offer to purchase Securities and the Company shall
have the sole right to accept offers to purchase Securities and may reject any such offer, in whole or in part. Subject to the terms
and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall be made at one or more closings (each
a &ldquo;<U>Closing</U>&rdquo; and the date on which each Closing occurs, a &ldquo;<U>Closing Date</U>&rdquo;). The Closing of the issuance
of the Securities shall occur via &ldquo;Delivery Versus Payment&rdquo;, i.e., on the Closing Date, the Company shall issue the Securities
directly to the account designated by the Placement Agent and, upon receipt of such Securities, the Placement Agent shall electronically
deliver such Securities to the applicable Investor and payment shall be made by the Placement Agent (or its clearing firm) by wire transfer
to the Company. As compensation for services rendered, on each Closing Date, the Company shall pay to the Placement Agent the fees and
expenses set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;A
cash fee equal to 6% of the gross proceeds received by the Company from the sale of the Securities at the closing of the Offering (the
&ldquo;<U>Closing</U>&rdquo;) to any Investor in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;The
Company agrees to reimburse Placement Agent&rsquo;s legal expenses up to $135,000, payable immediately upon the Closing of the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;The
term of the Placement Agent&rsquo;s exclusive engagement will be until the Closing; <U>provided</U>, <U>however</U>, that a party hereto
may terminate the engagement with respect to itself at any time upon 10 days written notice to the other parties. Notwithstanding anything
to the contrary contained herein, the provisions concerning confidentiality, indemnification, and contribution contained herein and the
Company&rsquo;s obligations contained in the indemnification provisions will survive any expiration or termination of this Agreement,
and the Company&rsquo;s obligation to pay fees actually earned and payable and to reimburse expenses actually incurred and reimbursable
pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rule 5110(g), will survive any expiration or termination
of this Agreement. Nothing in this Agreement shall be construed to limit the ability of the Placement Agent or its Affiliates to pursue,
investigate, analyze, invest in, or engage in investment banking, financial advisory, or any other business relationship with Persons
(as defined below) other than the Company. As used herein (i) &ldquo;Persons&rdquo; means an individual or corporation, partnership,
trust, incorporated, or unincorporated association, joint venture, limited liability company, joint stock company, government (or an
agency or subdivision thereof), or other entity of any kind and (ii) &ldquo;Affiliate&rdquo; means any Person that, directly or indirectly
through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and
construed under Rule 405 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.&nbsp;Representations, Warranties and Covenants of the Company</B>. Except as set forth in the SEC Reports (as hereafter defined), the
Company hereby represents, warrants, and covenants to the Placement Agent as of the date hereof, and as of each Closing Date, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Securities
Law Filings</U>. The Company has filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) the Registration
Statement under the Securities Act, which was filed on October 16, 2024 and declared effective on October 31, 2024 for the registration
of the Shares under the Securities Act. Following the determination of pricing among the Company and the prospective Investors introduced
to the Company by Placement Agent, and subject to the Company&rsquo;s acceptance of such Investors&rsquo; offers to purchase the Securities
and their respective execution and delivery of Purchase Agreements, the Company will file with the Commission pursuant to Rules 430A
and 424(b) under the Securities Act, and the rules and regulations (the &ldquo;<U>Rules and Regulations</U>&rdquo;) of the Commission
promulgated thereunder, a final prospectus supplement relating to the placement of the Shares, their respective pricings and the plan
of distribution thereof and will advise the Placement Agent of all further information (financial and other) with respect to the Company
required to be set forth therein. Such registration statement, at any given time, including the exhibits thereto filed at such time,
as amended at such time, is hereinafter called the &ldquo;<U>Registration Statement</U>&rdquo;; such prospectus in the form in which
it appears in the Registration Statement at the time of effectiveness, together with any preliminary prospectus supplement relating to
the Offering, is hereinafter called the &ldquo;<U>Base Prospectus</U>&rdquo;; and the final prospectus supplement, in the form in which
it is filed with the Commission pursuant to Rule 424(b) (including the Base Prospectus as it may be amended or supplemented) is hereinafter
called the &ldquo;<U>Final Prospectus</U>.&rdquo; The Registration Statement at the time it originally became effective is hereinafter
called the &ldquo;<U>Original Registration Statement</U>.&rdquo; Any reference in this Agreement to the Registration Statement, the Original
Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement, or the Final Prospectus shall be deemed to refer
to and include the documents incorporated by reference therein (the &ldquo;<U>Incorporated Documents</U>&rdquo;), if any, which were
or are filed under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), at any given time, as the
case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment,&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Original Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement,
or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the date of this
Agreement, or the issue date of the Base Prospectus, the Preliminary Prospectus Supplement, or the Final Prospectus, as the case may
be, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules and other
information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set forth,&rdquo;
or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement, or the Final Prospectus
(and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information
which is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus, the Preliminary Prospectus
Supplement, or the Final Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, &ldquo;<U>Time of
Sale Disclosure Package</U>&rdquo; means the Base Prospectus, and any issuer free writing prospectus as defined in Rule 433 of the Act
(each, an &ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;), if any, that the parties hereto shall hereafter expressly agree in writing
to treat as part of the Time of Sale Disclosure Package. The term &ldquo;<U>any Prospectus</U>&rdquo; shall mean, as the context requires,
the Base Prospectus, the Final Prospectus, and any supplement to either thereof. The Company has not received any notice that the Commission
has issued or intends to issue a stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus
or any prospectus supplement thereto or intends to commence a proceeding for any such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Assurances</U>.
The Original Registration Statement, as amended (and any further documents to be filed with the Commission) contains all exhibits
and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the
time it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and did
not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading. The Base Prospectus, and the Final Prospectus, each as of its respective date, comply or
will comply in all material respects with the Securities Act and the applicable Rules and Regulations. Each of the Base Prospectus
and the Final Prospectus, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; <I>provided</I>, <I>however</I>, that this representation and warranty shall not apply
to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by the
Placement Agent expressly for use therein. The Incorporated Documents, when they were filed with the Commission, conformed in all
material respects to the requirements of the Exchange Act and the applicable Rules and Regulations promulgated thereunder, and none
of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a
material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference in the Base
Prospectus or Final Prospectus), in light of the circumstances under which they were made not misleading. No post-effective
amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually
or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. Except
for this Agreement, to the knowledge of the Company, there are no documents required to be filed with the Commission in connection
with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be
filed within the requisite time period. Except for this Agreement, there are no contracts or other documents required to be
described in the Base Prospectus or Final Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which
have not been described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Offering
Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to each
Closing Date, any offering material in connection with the Offering other than the Time of Sale Disclosure Package and any other materials
permitted by the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>Subsidiaries</U>.
Other than the wholly-owned Canadian subsidiary of the Company which was formed in August, 2025 named 1001304798 ONTARIO INC. for the
use of a new Canadian employee whom was not employed, all of the subsidiaries of the Company are set forth on Exhibit 21 of the Company&rsquo;s
Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The Company owns, directly or indirectly, all of the capital
stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital
stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe
for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction
Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted, except where the failure to be in good
standing could not reasonably be expected to have a Material Adverse Effect (as defined below). Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect
on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;)
and no action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened (a &ldquo;<U>Proceeding</U>&rdquo;) has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals (as defined below). This Agreement and each other Transaction Document to which it is
a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof
and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any lien, charge, pledge, security interest,
encumbrance, right of first refusal, preemptive right or other restriction (a &ldquo;<U>Lien</U>&rdquo;) upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as would not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing with
the Commission of the Final Prospectus, (ii) application(s) to each applicable Trading Market for the listing of the Shares, Pre-Funded
Warrant Shares and Common Warrant Shares for trading thereon in the time and manner required thereby, (iii) such filings as are required
to be made under applicable state securities laws and (iv) such approval as may be required by the rules and regulations of the applicable
Trading Market from the stockholders of the Company with respect to the issuance of all the Warrants Shares underlying the Common Warrants
upon exercise thereof (the &ldquo;<U>Stockholder Approvals</U>&rdquo;). A &ldquo;<U>Trading Market</U>&rdquo; means any of the following
markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq
Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of
the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>Issuance
of the Securities; Registration</U>. The Shares have been duly authorized for issuance and sale pursuant to the Transaction Documents
and, when issued and delivered by the Company against payment therefor pursuant to the applicable Transaction Documents, will be validly
issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. Following receipt of the Stockholder Approvals,
the Common Warrants and the Pre-Funded Warrants will have been duly authorized by the Company and, when executed and delivered by the
Company in accordance with the applicable Transaction Documents, will constitute valid and legally binding agreements of the Company
enforceable against the Company in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency
or similar laws affecting creditors&rsquo; rights generally or by equitable principles relating to enforceability. The Common Warrant
Shares and Pre-Funded Warrant Shares have been duly authorized for issuance and sale pursuant to the Common Warrants and Pre-Funded Warrants
and, when issued and delivered by the Company against payment therefor pursuant to the Common Warrants or Pre-Funded Warrants, as the
case may be, will be validly issued, fully paid and nonassessable. The Company has prepared and filed the Registration Statement in conformity
with the requirements of the Securities Act, which became effective on October 31, 2024, including the Prospectus, and such amendments
and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities
Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of
the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the
Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Final
Prospectus with the Commission pursuant to Rule 424(b) and within the time frame required thereby. At the time the Registration Statement
and any amendments thereto became effective, at the date of this Agreement and at the Closings, the Registration Statement and any amendments
thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or
supplement thereto was issued and at the Closings, conformed and will conform in all material respects to the requirements of the Securities
Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading. The Company was at the time of the
filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it
meets the transaction requirements as set forth in General Instruction I.B.1 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;<U>Capitalization</U>.
The Company has an authorized and outstanding capitalization as set forth in the SEC Reports. The Company has not issued any capital
stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options
under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee
stock purchase plans, pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently
filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or
any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and
sale of the Shares and as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable
for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional
shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Shares will not obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Investors). There are
no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange
or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued,
fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There
are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which
the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus, being
collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such
time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC
Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of
the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result in
a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be
reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company
has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company
has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The
Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of
the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects,
properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that has not been publicly disclosed at least one Trading Day prior to the
date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&nbsp;<U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;)
which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities
or (ii) would, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither
the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation
of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or to the Company&rsquo;s
knowledge any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&nbsp;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their
relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary, to its respective knowledge: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as would not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)&nbsp;<U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, including
the Department of Transportation and the Federal Aviation Administration, except where the failure to possess such permits would not
reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any
Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except
where the failure to so comply would not reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two years from the date of this Agreement,
except where such expiration, termination or abandonment would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements
included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate
or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect.
To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another
Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect
the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)&nbsp;<U>Open
Source Software</U>. (i) To the best of the Company&rsquo;s knowledge, the Company uses and has used any and all software and other materials
distributed under a &ldquo;free,&rdquo; &ldquo;open source,&rdquo; or similar licensing model (including but not limited to the MIT License,
Apache License, GNU General Public License, GNU Lesser General Public License and GNU Affero General Public License) (&ldquo;<U>Open
Source Software</U>&rdquo;) in compliance with all license terms applicable to such Open Source Software; and (ii) the Company has not
used or distributed and does not use or distribute any Open Source Software in any manner that requires or has required (A) the Company
to permit reverse engineering of any software code or other technology owned by the Company or (B) any software code or other technology
owned by the Company to be (1) disclosed or distributed in source code form, (2) licensed for the purpose of making derivative works
or (3) redistributed at no charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)&nbsp;<U>Data
Security</U>. (i) To the best of the Company&rsquo;s knowledge, the Company has complied and is presently in compliance with all internal
and external privacy policies, contractual obligations, applicable laws, statutes, judgments, orders, rules and regulations of any court
or arbitrator or other governmental or regulatory authority and any other legal obligations, in each case, relating to the collection,
use, transfer, import, export, storage, protection, disposal and disclosure by the Company of personal, personally identifiable, household,
sensitive, confidential or regulated data (&ldquo;Data Security Obligations&rdquo;, and such data, &ldquo;Data&rdquo;); (ii) the Company
has not received any notification of or complaint regarding and is unaware of any other facts that, individually or in the aggregate,
would reasonably indicate non-compliance with any Data Security Obligation; and (iii) there is no action, suit or proceeding by or before
any court or governmental agency, authority or body pending or threatened alleging non-compliance with any Data Security Obligation nor
are there any incidents under internal review or investigations relating to the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;<U>Data
Protection; No Breaches</U>. To the best of the Company&rsquo;s knowledge, the Company&rsquo;s information technology assets and equipment,
computers, systems, networks, hardware, software, websites, applications, and databases are adequate for, and operate and perform in
all material respects as required in connection with, the operation of the business of the Company as currently conducted, free and clear
of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company has taken commercially reasonable
efforts to protect the information technology systems and Data used in connection with the operation of the Company&rsquo;s business.
Without limiting the foregoing, the Company has used reasonable efforts to establish and maintain reasonable information technology,
information security, cyber security and data protection controls, policies and procedures, including oversight, access controls, encryption,
technological and physical safeguards and business continuity/disaster recovery and security plans that are designed to protect against
and prevent breach, destruction, loss, unauthorized distribution, use, access, disablement, misappropriation or modification, or other
compromise or misuse of or relating to any information technology system or Data used in connection with the operation of the Company&rsquo;s
business (&ldquo;Breach&rdquo;). There has been no such Breach, and the Company has not been notified of and has no knowledge of any
event or condition that would reasonably be expected to result in, any such Breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)&nbsp;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports and the sale of Securities hereunder, none of the officers
or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary
is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors),
including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to
or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any
such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess
of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on
behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. Although the Company is a public reporting company, it qualifies as a non-accelerated filer/emerging
growth company/smaller reporting company and is therefore not currently subject to certain compliance requirements under the Sarbanes-Oxley
Act of 2002. When applicable, the Company anticipates it and the Subsidiaries shall be in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof. Except as set forth in the SEC Reports, the Company
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the
Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the
disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed
periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently
filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls
and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal
control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)&nbsp;<U>Certain
Fees</U>. Except for (i) fees payable by the Company to the Placement Agent and (ii) warrants being issued by the Company pursuant to
that certain Confirmation Agreement, dated as of October 14, 2025 between Spectral AI, Inc. and Dominari Securities, LLC (the &ldquo;<U>Confirmation
Agreement&rdquo;)</U>, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to
any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Registration Rights</U>. Except as (i) set forth in the SEC Reports or (ii) pursuant to the Confirmation Agreement, no Person has
any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">(cc) <U>Listing and Maintenance Requirements</U>. The Common Stock
is registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge
is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received
any notification that the Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding the
date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the
Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to
believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The
Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)&nbsp;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Investors as a result of the Investors and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance
of the Securities and the Investors&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)&nbsp;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the date hereof, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of
the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)&nbsp;<U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all
foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for
periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount
claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis
for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Accountants</U>. The Company&rsquo;s accounting firm is Forvis Mazars LLP. To the knowledge and belief of the Company, such accounting
firm is a registered public accounting firm as required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;<U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale
or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the
Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of
the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)&nbsp;<U>Cybersecurity</U>.
(i)(x) To the Company&rsquo;s knowledge, there has been no security breach or other compromise of or relating to any of the Company&rsquo;s
or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its
respective customers, employees, suppliers, vendors and to the Company&rsquo;s knowledge any third party data maintained by or on behalf
of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have
not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable
laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such
IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or affiliate of the Company or any Subsidiary is currently subject to any sanctions administered or enforced by the U.S.
Government, including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department
of State and including, without limitation, the designation as a &ldquo;specially designated national&rdquo; or &ldquo;blocked person&rdquo;
(&ldquo;<U>Sanctions</U>&rdquo;). Since April 24, 2019, the Company nor any of its Subsidiaries have knowingly engaged in or are now
knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject
or the target of Sanctions or with any Sanctioned Country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Certificates</U>. Any certificate signed by an officer of the Company and delivered to the Placement Agent or to counsel for the Placement
Agent shall be deemed to be a representation and warranty by the Company (and not in such officer&rsquo;s personal capacity) to the Placement
Agent as to the matters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Reliance</U>. The Company acknowledges that the Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations
and warranties and hereby consents to such reliance. <B>The Company hereby represents, warrants and covenants to the Placement Agent
that the Placement Agent may rely on all of the representations, warranties and covenants made to the Investors in the Purchase Agreement
and any certificates provided to the Investors pursuant thereto.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>Forward-Looking Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Statistical or Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference
in the Time of Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to
be reliable and accurate in all material respects, and such data agree with the sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>FINRA Matters</U>. All of the information provided to the Placement Agent or to counsel for the Placement Agent by the Company, its
counsel, to the Company&rsquo;s knowledge, its officers and directors and, to the Company&rsquo;s knowledge, the holders of any securities
(debt or equity) or options to acquire any securities of the Company in connection with the Offering is true, complete, correct and compliant
with the Financial Industry Regulatory Authority&rsquo;s (&ldquo;<U>FINRA</U>&rdquo;) rules in all material respects, and any letters,
filings or other supplemental information provided to FINRA pursuant to FINRA Rules is true, complete and correct in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>FINRA Affiliations</U>. There are no affiliations with any FINRA member firm that is participating in the Offering among the Company&rsquo;s
officers, directors or, to the knowledge of the Company, any 5% or greater stockholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&nbsp;<U>Parties
to Lock-Up Agreements</U>. The Company has furnished to the Placement Agent a letter agreement in form and substance reasonably acceptable
to the Placement Agent (the &ldquo;<U>Lock-up Agreement</U>&rdquo;) from certain executive officers, directors and stockholders of the
Company. If any additional persons shall become directors or officers of the Company prior to the end of the 30-day restricted period
after the date of the Prospectus, the Company shall cause each such person, prior to or contemporaneously with their appointment or election
as a director or officer of the Company, to execute and deliver to the Placement Agent a Lock-up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.&nbsp;Delivery and Payment</B>. Each Closing shall occur at the offices of the Company or such place as shall be agreed upon by the Placement
Agent and the Company). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities
sold on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall
be registered in such name or names and shall be in such denominations, as the Placement Agent may each request at least one business
day before the time of purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deliveries
of the documents with respect to the purchase of the Securities, if any, shall be made at such place as shall be agreed upon by the parties.
All actions taken at a Closing shall be deemed to have occurred simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4. Covenants and Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Registration
Statement Matters</U>. The Company will advise the Placement Agent promptly after it receives notice thereof of the time when any amendment
to the Registration Statement has been filed or becomes effective or any supplement to the Base Prospectus or the Final Prospectus has
been filed and will furnish the Placement Agent with copies thereof. The Company will file promptly all reports and any definitive proxy
or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange
Act subsequent to the date of any Prospectus and for so long as the delivery of a prospectus is required in connection with the Offering.
The Company will advise the Placement Agent, promptly after it receives notice thereof (i) of any request by the Commission to amend
the Registration Statement or to amend or supplement any Prospectus or for additional information, and (ii) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any order directed
at any Incorporated Document, if any, or any amendment or supplement thereto or any order preventing or suspending the use of the Base
Prospectus or the Final Prospectus or any prospectus supplement or any amendment or supplement thereto or any post-effective amendment
to the Registration Statement, of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, of the
institution or threatened institution of any proceeding for any such purpose, or of any request by the Commission for the amending or
supplementing of the Registration Statement or a Prospectus or for additional information. The Company shall use its best efforts to
prevent the issuance of any such stop order or prevention or suspension of such use. If the Commission shall enter any such stop order
or order or notice of prevention or suspension at any time, the Company will use its best efforts to obtain the lifting of such order
at the earliest possible moment, or will file a new registration statement and use its best efforts to have such new registration statement
declared effective as soon as practicable. Additionally, the Company agrees, in connection with the Offering, that it shall comply with
the provisions of Rules 424(b), 430A, 430B, and 430C, as applicable, under the Securities Act, including with respect to the timely filing
of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such Rule 424(b) are
received in a timely manner by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Blue
Sky Compliance</U>. If applicable, the Company will reasonably cooperate with the Placement Agent and the Investors in endeavoring to
qualify the Securities for sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and
the Investors may reasonably request and will make such applications, file such documents, and furnish such information as may be reasonably
required for that purpose, provided the Company shall not be required to qualify as a foreign corporation or to file a general consent
to service of process in any jurisdiction where it is not now so qualified or required to file such a consent, and provided further that
the Company shall not be required to produce any new disclosure document. The Company will, from time to time, prepare and file such
statements, reports, and other documents as are or may be required to continue such qualifications in effect for so long a period as
the Placement Agent may reasonably request for distribution of the Securities. The Company will advise the Placement Agent promptly of
the suspension of the qualification or registration of (or any such exemption relating to) the Securities for offering, sale, or trading
in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order
suspending such qualification, registration, or exemption, the Company shall use its commercially reasonable efforts to obtain the withdrawal
thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Amendments
and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and the
rules and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Securities as contemplated
in this Agreement, the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required by law to be
delivered in connection with the distribution of Securities contemplated by the Incorporated Documents, this Agreement, and any Prospectus
(the &ldquo;<U>Prospectus Delivery Period</U>&rdquo;), any event shall occur as a result of which, in the judgment of the Company or
in the reasonable opinion of the Placement Agent or counsel for the Placement Agent, it becomes necessary to amend or supplement the
Incorporated Documents or any Prospectus in order to make the statements therein, in light of the circumstances under which they were
made, as the case may be, not misleading, or if it is necessary at any time to amend or supplement the Incorporated Documents or any
Prospectus or to file under the Exchange Act any Incorporated Document to comply with any law, the Company will promptly prepare and
file with the Commission, and furnish at its own expense to the Placement Agent and to dealers, an appropriate amendment to the Registration
Statement or supplement to the Registration Statement, the Incorporated Documents or any Prospectus that is necessary in order to make
the statements in the Incorporated Documents and any Prospectus as so amended or supplemented, in light of the circumstances under which
they were made, as the case may be, not misleading, or so that the Registration Statement, the Incorporated Documents or any Prospectus,
as so amended or supplemented, will comply with law. Before amending the Registration Statement or supplementing the Incorporated Documents
or any Prospectus in connection with the Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment
or supplement and will not file any such amendment or supplement to which the Placement Agent reasonably objects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>Copies
of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Placement Agent, without charge, during the period
beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of any Prospectus or prospectus
supplement and any amendments and supplements thereto, as the Placement Agent may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Transfer
Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Earnings
Statement</U>. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later
than 18 months after the last Closing Date, the Company will make generally available to its security holders and to the Placement Agent
an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies the
provisions of Section 11(a) and Rule 158 under the Securities Act, the filing of such earnings statement via the Electronic Data Gathering,
Analysis, and Retrieval system shall satisfy the Company&rsquo;s obligations under this Section 4(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<U>Periodic
Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission
and the Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and in the manner
required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;<U>Additional
Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or
the Investors deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable
to the Placement Agent and the Investors. The Company agrees that the Placement Agent may rely upon, and each is a third party beneficiary
of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription or other agreement with
Investors in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>No
Manipulation of Price</U><I>. </I>The Company will not take, directly or indirectly, any action designed to cause or result in, or that
has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;<U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of
Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent&rsquo;s prior written
consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&nbsp;<U>Announcement
of Offering</U>. The Company acknowledges and agrees that the Placement Agent and its counsel may, subsequent to the Closing, make public
its involvement with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&nbsp;<U>Reliance
on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal, tax and accounting advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&nbsp;<U>Research
Matters</U>. By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable
or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent&rsquo;s selection
as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable
or any research coverage of the Company. In accordance with FINRA Rule 2241(b)(2)(k), the parties acknowledge and agree that the Placement
Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change
research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&nbsp;<U>Exchange
Listing</U>. The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares, the Pre-Funded Warrant
Shares and the Common Warrant Shares on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&nbsp;<U>Share
Reserve</U>. Following receipt of Stockholder Approvals, the shares of Common Stock issuable upon exercise of the Warrants and the Pre-Funded
Warrants shall be duly authorized and reserved for issuance for the purpose of enabling the Company to issue Shares pursuant to this
Agreement and Warrant Shares pursuant to any exercise of the Pre-Funded Warrants and Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)&nbsp;<U>Private
Placement; No General Solicitation</U>. Assuming the accuracy of the Investors&rsquo; representations and warranties set forth in the
Purchase Agreements, no registration under the Securities Act is required for the offer and sale of the Pre-Funded Warrants and Common
Warrants by the Company to the Investors as contemplated hereby. The issuance and sale of the Securities pursuant to the Transaction
Documents does not contravene the rules and regulations of the Trading Market. Neither the Company nor any Person acting on behalf of
the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered
the Securities for sale only to the Investors and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5. Conditions of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the
accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date
hereof and as of each Closing Date, to the timely performance by each of the Company of its covenants and other obligations hereunder
on and as of such dates, and to each of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Accountants&rsquo;
Comfort Letter</U>. On the Closing Date (as defined in the Purchase Agreement), the Placement Agent shall have received, and the Company
shall have caused to be delivered to the Placement Agent, a letter from KPMG LLP (the former independent registered public accounting
firm of the Company), addressed to the Placement Agent, dated as of the Closing Date, in form and substance satisfactory to the Placement
Agent. The letter shall not disclose any change in the condition (financial or other), earnings, operations, business or prospects of
the Company from that set forth in the Incorporated Documents or the applicable Prospectus or prospectus supplement, which, in the Placement
Agent&rsquo;s sole judgment, is material and adverse and that makes it, in the Placement Agent&rsquo;s sole judgment, impracticable or inadvisable
to proceed with the Offering of the Shares as contemplated by such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Compliance
with Registration Requirements; No Stop Order; No Objection from the FINRA.</U> Each Prospectus (in accordance with Rule 424(b)) and
&ldquo;<U>free writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act), if any, shall have been duly filed with
the Commission, as appropriate; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have
been issued and no proceeding for that purpose shall have been initiated or, to the Company&rsquo;s knowledge, threatened by the Commission;
no order preventing or suspending the use of any Prospectus shall have been issued and no proceeding for that purpose shall have been
initiated or, to the Company&rsquo;s knowledge, threatened by the Commission; no order having the effect of ceasing or suspending the
distribution of the Shares or any other securities of the Company shall have been issued by any securities commission, securities regulatory
authority or stock exchange and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of
the Company, contemplated by any securities commission, securities regulatory authority or stock exchange; all requests for additional
information on the part of the Commission shall have been complied with; and the FINRA shall have raised no objection to the fairness
and reasonableness of the placement terms and arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement, and
any Prospectus, and the registration, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably
satisfactory to the Placement Agent&rsquo;s counsel, and such counsel shall have been furnished with such papers and information as it
may reasonably have requested to enable such counsel to pass upon the matters referred to in this Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>No
Material Adverse Effect</U>. Subsequent to the execution and delivery of this Agreement and prior to each Closing Date, in the Placement
Agent&rsquo;s sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Opinion
of Counsel for the Company</U>. The Placement Agent shall have received on each Closing Date the favorable opinion of US legal counsel
to the Company, dated as of such Closing Date, including, without limitation, a negative assurance letter addressed to the Placement
Agent and in form and substance reasonably satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Letter
from Chief Financial Officer of the Company</U>. On the Closing Date, the Placement Agent shall receive a signed letter from the Chief
Financial Officer of the Company addressed to the Placement Agent and the Purchasers, in form and substance reasonably satisfactory to
the Placement Agent and its counsel, containing statements and information of the type ordinarily included in chief financial officer
certificates to placement agents with respect to the financial statements and certain financial information contained in or incorporated
by reference into the Registration Statement, the Prospectus, and the Prospectus Supplement. The letter shall not disclose any change
in the condition (financial or other), earnings, operations, business or prospects of the Company from that set forth in the Incorporated
Documents or the applicable Prospectus or prospectus supplement, which, in the Placement Agent&rsquo;s sole judgment, is material and
adverse and that makes it, in the Placement Agent&rsquo;s sole judgment, impracticable or inadvisable to proceed with the Offering of
the Securities as contemplated by such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<U>Officers&rsquo;
Certificate</U>. The Placement Agent shall have received on each Closing Date a certificate of the Company, dated as of such Closing
Date, signed by the Chief Executive Officer and the Chief Financial Officer of the Company, to the effect that, and the Placement Agent
shall be satisfied that, the signers of such certificate have reviewed the Registration Statement, the Incorporated Documents, any prospectus
supplement, and this Agreement and to the further effect that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;The
representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date, and
the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior
to such Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;No
stop order suspending the effectiveness of the Registration Statement or the use of any Prospectus has been issued and no proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Shares or any other securities of the Company has been issued by any
securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose have
been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;When
the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate,
the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with the Commission,
and any Prospectus, contained all material information required to be included therein by the Securities Act and the Exchange Act and
the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects conformed to the
requirements of the Securities Act and the Exchange Act and the applicable rules and regulations of the Commission thereunder, as the
case may be, and the Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations
and warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity
with information furnished in writing to the Company by the Placement Agent expressly for use therein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;Subsequent
to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and any Prospectus,
there has not been: (a) any Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries taken as
a whole, except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material
to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary
course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise of outstanding stock
options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (e) any dividend or distribution of any kind declared,
paid or made on the capital stock of the Company; or (f) any loss or damage (whether or not insured) to the property of the Company or
any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;<U>Secretary&rsquo;s
Certificate</U>. At each Closing Date, the Placement Agent shall have received a certificate of the Company signed by the Secretary or
another authorized officer of the Company, dated such Closing Date certifying on behalf of the Company and not in an individual capacity:
(i) that the amended and restated certificate of incorporation of the Company is true and complete, has not been modified and is in full
force and effect; (ii) that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering are in full force and
effect and have not been modified; and (iii) as to the incumbency of the officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>Stock
Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market, and the
Company shall not have taken any action designed to terminate, or likely to have the effect of terminating, the registration of the Common
Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall the Company
have received any information suggesting that the Commission or the Trading Market is contemplating terminating such registration or
listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;<U>Lock-up
Agreements</U>. The Lock-Up Agreements relating to sales and certain other dispositions of shares of Common Stock or certain other securities
shall be in full force and effect on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&nbsp;<U>Additional
Documents</U>. On or before each Closing Date, the Placement Agent and counsel for the Placement Agent shall have received such information
and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as
contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of
the conditions or agreements, herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by
the Placement Agent by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability
on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution)
and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6. Payment of Expenses</B>. The Company agrees to pay all costs, fees, and expenses incurred by the Company in connection with the performance
of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses
incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs); (ii) all fees and
expenses of the registrar and transfer agent of the Common Stock; (iii) all necessary issue, transfer and other stamp taxes in connection
with the issuance and sale of the Securities; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified
public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping
and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts),
the Base Prospectus, the Final Prospectus and each prospectus supplement, and all amendments and supplements thereto, and this Agreement;
(vi) all filing fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company or the Placement Agent in connection with
qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities for offer
and sale under the state securities or blue sky laws or the securities laws of any other country, and, if requested by the Placement
Agent, preparing and printing a &ldquo;Blue Sky Survey,&rdquo; an &ldquo;International Blue Sky Survey&rdquo; or other memorandum, and
any supplements thereto, advising the Placement Agent of such qualifications, registrations and exemptions (with any such fees of Placement
Agent counsel incurred pursuant to this Section 6(vi) being included up to $135,000 in fees that are reimbursable pursuant to Section
1(a)(ii)); (vii) if applicable, the filing fees incident to the review and approval by the FINRA of the Placement Agent&rsquo;s participation
in the offering and distribution of the Securities; (viii) the fees and expenses associated with listing the Shares on the Trading Market;
(xi) all costs and expenses incident to the travel and accommodation of the Company&rsquo;s and the Placement Agent&rsquo;s employees on the
&ldquo;<U>roadshow</U>,&rdquo; if any; and (xii) all other fees, costs and expenses referred to in Part II of the Registration Statement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.&nbsp;Indemnification and Contribution<FONT STYLE="font-weight: normal">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;The
Company agrees to indemnify and hold harmless the Placement Agent, its affiliates and each person controlling the Placement Agent (within
the meaning of Section 15 of the Securities Act), and the directors, officers, agents assisting with the Offering, and employees of the
Placement Agent, its affiliates and each such controlling person (the Placement Agent, and each such entity or person. an &ldquo;<U>Indemnified
Person</U>&rdquo;) from and against any losses, claims, damages, judgments, assessments, costs, and other liabilities (collectively,
the &ldquo;<U>Liabilities</U>&rdquo;), and shall reimburse each Indemnified Person for all reasonable and documented out of pocket fees
and expenses (including the reasonable documented and out of pocket fees and expenses of one counsel for all Indemnified Persons, except
as otherwise expressly provided herein) (collectively, the &ldquo;<U>Expenses</U>&rdquo;) as they are incurred by an Indemnified Person
in investigating, preparing, pursuing, or defending any Actions, whether or not any Indemnified Person is a party thereto, (i) caused
by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, any Incorporated Document, or any Prospectus or by any omission or alleged omission to state therein a material fact necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading (other than untrue statements
or alleged untrue statements in, or omissions or alleged omissions from, information relating to an Indemnified Person furnished in writing
by or on behalf of such Indemnified Person expressly for use in the Incorporated Documents) or (ii) otherwise arising out of or in connection
with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated
thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or transactions; <U>provided, however</U>,
that, in the case of clause (ii) only, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person
that are finally judicially determined to have resulted primarily from such Indemnified Person&rsquo;s (x) negligence, gross negligence,
willful misconduct, or bad faith in connection with any of the advice, actions, inactions, or services referred to above or (y) use of
any offering materials or information concerning the Company in connection with the offer or sale of the Securities in the Offering which
were not authorized for such use by the Company and which use constitutes negligence, gross negligence, or willful misconduct. The Company
also agrees to reimburse each Indemnified Person for all Expenses as they are incurred in connection with enforcing such Indemnified
Person&rsquo;s rights under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;Upon
receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity may be
sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Placement Agent, assume the defense of any such Action including the employment of counsel reasonably satisfactory
to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel, or (ii) the named parties
to any such Action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall
have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Action or related Actions, in addition to any local counsel. The Company shall not be liable for any settlement
of any Action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of the Placement Agent (which shall not be unreasonably withheld), settle, compromise, or consent to the entry
of any judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification or contribution
may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent, or termination
includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for which indemnification
or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as such expense, loss, damage, or liability is incurred and is due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;In
the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other
hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate,
as well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of
fees actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the
Company, on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed
to be in the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received by
the Company in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated,
bears to (b) the fees to be received by the Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent
misrepresentation within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party
who was not guilty of fraudulent misrepresentation.</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;The
Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services,
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted
primarily from such Indemnified Person&rsquo;s negligence, gross negligence or willful misconduct in connection with any such advice,
actions, inactions or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;The
reimbursement, indemnity, and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services under
or in connection with, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. Representations and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other
statements of the Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant
to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent,
the Company, or any of its or their respective partners, officers, or directors or any controlling person, as the case may be, and will
survive delivery of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to a Placement Agent,
or to the Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity,
contribution and reimbursement agreements contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Notices</B>. All communications hereunder shall be in writing and shall be mailed, hand delivered or e-mailed and confirmed to the
parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Placement Agent to the address set forth above, attention: Jeff Peterson, email: jeffpeterson@northlandcapitalmarkets.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faegre
Drinker Biddle &amp; Reath LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000 Wells Fargo Center</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90
S. Seventh Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minneapolis, Minnesota 55402</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Jonathan Zimmerman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
Jonathan.zimmerman@faegredrinker.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spectral
AI, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2515
McKinney Ave, Suite 1000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
TX 75201</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Vincent Capone</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
vcapone@spectral-ai.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy (which shall not constitute notice) to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reed
Smith LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2850
N. Harwood Street, Suite 1500</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
TX 75201</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Lynwood E. Reinhardt</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: lreinhardt@reedsmith.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address for receipt of communications by giving written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. Successors</B>. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees,
officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative,
and no other person will have any right or obligation hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11. Partial Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of
this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12. Governing Law Provisions</B>. This Agreement shall be deemed to have been made and delivered in New York City and both this engagement
letter and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other
respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Placement
Agent and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this engagement letter and/or
the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue of
any such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the
Placement Agent and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such
suit, action or proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern
District of New York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall
be deemed in every respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process
upon the Placement Agent mailed by certified mail to the Placement Agent&rsquo;s address shall be deemed in every respect effective service
process upon the Placement Agent, in any such suit, action or proceeding. Notwithstanding any provision of this engagement letter to
the contrary, the Company agrees that neither the Placement Agent nor its affiliates, and the respective officers, directors, employees,
agents and representatives of the Placement Agent, its affiliates and each other person, if any, controlling the Placement Agent or any
of its affiliates, shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection
with the engagement and transaction described herein except for any such liability for losses, claims, damages or liabilities incurred
by us that are finally judicially determined to have resulted from the willful misconduct or gross negligence of such individuals or
entities. If either party shall commence an action or proceeding to enforce any provision of this Agreement, then the prevailing party
in such action or proceeding shall be reimbursed by the other party for its reasonable attorney&rsquo;s fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
13. General Provisions<FONT STYLE="font-weight: normal">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or
more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the
same instrument. Electronically scanned and transmitted signatures (including by email attachment) and electronic signatures (including
by DocuSign) shall be deemed originals for all purposes of this Agreement. This Agreement may not be amended or modified unless in writing
by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom
the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction
or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;The
Company acknowledges that in connection with the Offering: (i) the Placement Agent has acted at arms length, is not agent of, and owes
no fiduciary duties to the Company, any officer or director of the Company or any other person affiliated with any of them, (ii) the
Placement Agent owes the Company only those duties and obligations set forth in this Agreement, and (iii) the Placement Agent may have
interests that differ from those of the Company. The Company waives to the full extent permitted by applicable law any claims it may
have against the Placement Agent arising from an alleged breach of fiduciary duty in connection with the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 0pt; text-align: left; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; width: 60%; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; text-align: justify; text-indent: 0pt; width: 4%; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; text-align: justify; text-indent: 0pt; width: 6%; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; text-align: justify; text-indent: 0pt; width: 30%; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECTRAL
    AI, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; text-align: left; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-top: 0pt; border-bottom: Black 1.5pt solid; padding-right: 0pt; text-align: justify; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/
J. Michael DiMaio, MD</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; text-align: left; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; text-align: justify; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; text-align: left; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
    Michael DiMaio, MD</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; text-align: left; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0pt; text-align: justify; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding-top: 0pt; text-align: left; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board of Directors</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Placement Agency Agreement is hereby confirmed and accepted as of the date first above written.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NORTHLAND SECURITIES, INC.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0in">/s/ Jack B. Kiernan, Jr.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    B. Kiernan, Jr.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director, Head of Life Sciences</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ea026231501ex10-3_spectral.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT, DATED OCTOBER 24, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>REGISTRATION RIGHTS AGREEMENT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This REGISTRATION
RIGHTS AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of October 24, 2025, by and among Spectral AI, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and the &ldquo;Investors&rdquo; named in that certain Securities Purchase Agreement
by and among the Company and the Investors, dated as of the date hereof (the &ldquo;<U>Purchase Agreement</U>&rdquo;). Capitalized terms
used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The parties hereby agree as follows:</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in"> 1. <U>Definitions</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">As used in this Agreement, the following terms shall have
the following meanings:</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Agreement</U>&rdquo; has the meaning set forth
in the first paragraph.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Allowed Delay</U>&rdquo; has the meaning
set forth in Section 2(c)(ii).</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Availability Date</U>&rdquo; has the meaning
set forth in Section 3(i).</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Company</U>&rdquo; has the meaning set forth
in the first paragraph.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Cut Back Shares</U>&rdquo; has the meaning
set forth in Section 2(e).</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Effectiveness Period</U>&rdquo; has the
meaning set forth in Section (a).</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&ldquo;<U>Filing Deadline</U>&rdquo; has the meaning
set forth in Section 2(a)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Investors</U>&rdquo; means the
Investors identified in the Purchase Agreement and any affiliate or permitted transferee of any Investor who is a subsequent holder of
Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means (i) the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement, with respect
to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments
and supplements to the prospectus, including post-effective amendments and all material incorporated by reference in such prospectus,
and (ii) any &ldquo;free writing prospectus&rdquo; as defined in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Purchase Agreement</U>&rdquo; has the meaning
set forth in the first paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Qualification Date</U>&rdquo; has the meaning
set forth in Section 2(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Qualification Deadline</U>&rdquo; has the
meaning set forth in Section 2(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Register</U>,&rdquo;
&ldquo;<U>registered</U>&rdquo; and &ldquo;<U>registration</U>&rdquo; refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such Registration
Statement or document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means (i) the Warrant Shares and (ii) any other securities issued or issuable with respect to or in exchange for
Warrant Shares, whether by merger, charter amendment or otherwise; provided, that a security shall cease to be a Registrable Security
upon the earliest of: (A) sale pursuant to a Registration Statement or Rule 144 under the Securities Act or (B) such security becoming
eligible for sale without restriction by the Investor holding such security pursuant to Rule 144, including without any manner of sale
or volume limitations, and without the requirement to be in compliance with Rule 144(c)(1) (or any successor thereto) promulgated under
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement of the Company under the Securities Act that covers the resale of any of the Registrable
Securities pursuant to the provisions of this Agreement, amendments and supplements to such Registration Statement, including post-effective
amendments, all exhibits and all material incorporated by reference in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Required Investors</U>&rdquo;
means the Investors holding a majority of the Registrable Securities outstanding from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Restriction Termination Date</U>&rdquo; has
the meaning set forth in Section 2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>SEC</U>&rdquo; means the U.S. Securities and
Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>SEC Restrictions</U>&rdquo; has the meaning set
forth in Section 2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&ldquo;<U>Shelf Registration Statement</U>&rdquo; has the
meaning set forth in Section 2(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 2. <U>Registration</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt"> (a) <U>Registration Statements</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -16.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(i)&nbsp;Promptly
following the date hereof but no later than ten (10) calendar days after the date hereof (the &ldquo;<U>Filing Deadline</U>&rdquo;), the
Company shall prepare and file with the SEC one Registration Statement covering the resale of all of the Registrable Securities. Subject
to any SEC comments, such Registration Statement shall include the plan of distribution, substantially in the form and substance attached
hereto as <U>Exhibit A</U>; provided, however, that no Investor shall be named as an &ldquo;underwriter&rdquo; in such Registration Statement
without the Investor&rsquo;s prior written consent. Such Registration Statement also shall cover, to the extent allowable under the Securities
Act and the rules promulgated thereunder (including Rule 416), such indeterminate number of additional shares of Common Stock resulting
from stock splits, stock dividends or similar transactions with respect to the Registrable Securities. Such Registration Statement (and
each amendment or supplement thereto) shall be provided in accordance with Section 3(c) to the Investors prior to its filing or other
submission. Notwithstanding the foregoing, if at the time the Company files the Registration Statement, the SEC is not then currently
reviewing certain filings by issuers, including the Registration Statement, due to a shutdown of the federal government or otherwise,
then the Company shall not include delaying amendment language in such filing of the Registration Statement such that the Registration
Statement shall become effective in accordance with Section 8(a) of the Securities Act within twenty (20) calendar days of such filing.
The Company shall take all actions reasonably necessary to maintain the continuous effectiveness of </FONT>the Registration Statement
thereafter in accordance with this Section 2(a)(i). The Company shall incorporate, if applicable, the language provided by Rule 473(b)
of the Securities Act of 1933 for the automatic effectiveness of the Registration Statement twenty (20) calendar days following filing
of an amendment to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;The
Registration Statement referred to in Section 2(a)(i) shall be on Form S-3. In the event that Form S-3 is not available for the registration
of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on such other
form as is available to the Company and (ii) so long as Registrable Securities remain outstanding, promptly following the date (the &ldquo;<U>Qualification
Date</U>&rdquo;) upon which the Company becomes eligible to use a registration statement on Form S-3 to register the Registrable Securities
for resale, but in no event more than thirty (30) days after the Qualification Date (the &ldquo;<U>Qualification Deadline</U>&rdquo;),
file a registration statement on Form S-3 covering the Registrable Securities (or a post-effective amendment on Form S-3 to a registration
statement on Form S-1) (a &ldquo;<U>Shelf Registration Statement</U>&rdquo;) and use commercially reasonable efforts to cause such Shelf
Registration Statement to be declared effective as promptly as practicable thereafter; provided that the Company shall maintain the effectiveness
of the Registration Statement then in effect until such time as a Shelf Registration Statement covering the Registrable Securities has
been declared effective by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Expenses</U>.
The Company will pay all expenses associated with each Registration Statement, including filing and printing fees, the Company&rsquo;s
own counsel and accounting fees and expenses, costs associated with clearing the Registrable Securities for sale under applicable state
securities laws and listing fees, but excluding discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar
securities industry professionals with respect to the Registrable Securities being sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> (c) <U>Effectiveness</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -16.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;Except
as otherwise provided in Section 2(a)(i), the Company shall use commercially reasonable efforts to have each Registration Statement declared
effective as soon as reasonably practicable after such Registration Statement has been filed with the SEC and in any event no later than
the earlier of (A) five (5) Business Days after the SEC informs the Company that no review of such Registration Statement will be made
or that the SEC has no further comments on such Registration Statement or (B) the 90th day after the Closing Date (or the 120th day after
the Closing Date if the SEC reviews such Registration Statement). The Company shall notify the Investors by facsimile or e-mail as promptly
as practicable, and in any event, within twenty-four (24) hours, after any Registration Statement is declared effective and shall provide
the Investors with copies of any related Prospectus to be used in connection with the sale or other disposition of the securities covered
thereby as may be requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(ii)&nbsp;For
not more than thirty (30) consecutive days or for a total of not more than sixty (60) days in any twelve (12) month period, the Company
may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section in the event that the Company
determines in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic information concerning the
Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company or
(B) amend or supplement the affected Registration Statement or the related Prospectus so that such </FONT>Registration Statement or Prospectus
shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein, in the case of the Prospectus in light of the circumstances under which they were made, not misleading (an
&ldquo;<U>Allowed Delay</U>&rdquo;); provided, that the Company shall promptly (a) notify each Investor in writing of the commencement
of an Allowed Delay, but shall not (without the prior written consent of an Investor) disclose to such Investor any material nonpublic
information giving rise to an Allowed Delay, (b) advise the Investors in writing to cease all sales under such Registration Statement
until the end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> (d) [Reserved.]</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -16.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;<U>Rule
415; Cutback</U>. If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in a
Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the
Securities Act or requires any Investor to be named as an &ldquo;underwriter,&rdquo; the Company shall use commercially reasonable
efforts to advocate before the SEC its reasonable position that the offering contemplated by such Registration Statement is a valid
secondary offering and not an offering &ldquo;by or on behalf of the issuer&rdquo; as defined in Rule 415 and that none of the
Investors is an &ldquo;underwriter.&rdquo; In the event that, despite the Company&rsquo;s commercially reasonable efforts and
compliance with the terms of this Section 2(e), the SEC does not alter its position, the Company shall (i) remove from such
Registration Statement such portion of the Registrable Securities (the &ldquo;<U>Cut Back Shares</U>&rdquo;) and/or (ii) agree to
such restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure the
Company&rsquo;s compliance with the requirements of Rule 415 (collectively, the &ldquo;<U>SEC Restrictions</U>&rdquo;); provided,
however, that the Company shall not agree to name any Investor as an &ldquo;underwriter&rdquo; in such Registration Statement
without the prior written consent of such Investor. Any cut-back imposed on the Investors pursuant to this Section 2(e) shall be
allocated among the Investors on a pro rata basis and shall be applied first to any of the Registrable Securities of such Investor
as such Investor shall designate, unless the SEC Restrictions otherwise require or provide or the Investors otherwise agree. No
liquidated damages shall accrue as to any Cut Back Shares until such date as the Company is able to effect the registration of such
Cut Back Shares in accordance with any SEC Restrictions applicable to such Cut Back Shares (such date, the &ldquo;<U>Restriction
Termination Date</U>&rdquo;). From and after the Restriction Termination Date applicable to any Cut Back Shares, all of the
provisions of this Section 2 (including the Company&rsquo;s obligations with respect to the filing of a Registration Statement and
its obligations to use commercially reasonable efforts to have such Registration Statement declared effective within the time
periods set forth herein and the liquidated damages provisions relating thereto) shall again be applicable to such Cut Back Shares;
provided, however, that (i) the Filing Deadline and/or the Qualification Deadline, as applicable, for such Registration Statement
including such Cut Back Shares shall be ten (10) Business Days after such Restriction Termination Date, and (ii) the date by which
the Company is required to obtain effectiveness with respect to such Cut Back Shares under Section 2(c) shall be the 90<FONT STYLE="font-size: 10pt">th</FONT>
day immediately after the Restriction Termination Date (or the 120<FONT STYLE="font-size: 10pt">th</FONT> day if the SEC reviews
such Registration Statement), provided, however, that if at the time the Company files the Registration Statement, the SEC is not
then currently reviewing certain filings by issuers, including the Registration Statement, due to a shutdown of the federal
government or otherwise, then the Company shall not include delaying amendment language in such filing of the Registration Statement
such that the Registration Statement shall become effective in accordance with Section 8(a) of the Securities Act within twenty (20)
calendar days of such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">3.&nbsp;<U>Company
Obligations</U>. The Company will use commercially reasonable efforts to effect the registration of the Registrable Securities in accordance
with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible: (a) use commercially reasonable efforts to
cause such Registration Statement to become effective and to remain continuously effective for a period that will terminate upon the earlier
of (i) the date on which all Registrable Securities covered by such Registration Statement, as amended from time to time, have been sold,
and (ii) the date on which all Warrant Shares cease to be Registrable Securities (the &ldquo;<U>Effectiveness Period</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;prepare
and file with the SEC such amendments and post-effective amendments to such Registration Statement and the related Prospectus as may be
necessary to keep such Registration Statement effective for the Effectiveness Period and to comply with the provisions of the Securities
Act and the Exchange Act with respect to the distribution of all of the Registrable Securities covered thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;provide
copies to and permit each Investor to review each Registration Statement and all amendments and supplements thereto no fewer than two
(2) days prior to their filing with the SEC and to furnish reasonable comments thereon;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;furnish
to each Investor whose Registrable Securities are included in any Registration Statement (i) promptly after the same is prepared and filed
with the SEC, if requested by the Investor, one (1) copy of any Registration Statement any amendment thereto, and each letter written
by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC,
in each case relating to such Registration Statement (other than any portion thereof which contains information for which the Company
has sought confidential treatment), and (ii) such number of copies of a Prospectus, including a preliminary Prospectus, and all amendments
and supplements thereto and such other documents as each Investor may reasonably request in order to facilitate the disposition of the
Registrable Securities owned by such Investor that are covered by such Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;use
commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii) if such order
is issued, obtain the withdrawal of any such order at the earliest practical moment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;prior
to any public offering of Registrable Securities, use commercially reasonable efforts to register or qualify or cooperate with the Investors
and their counsel in connection with the registration or qualification of such Registrable Securities for the offer and sale under the
securities or blue sky laws of such jurisdictions requested by the Investors and do any and all other commercially reasonable acts or
things necessary or advisable to enable the distribution in such jurisdictions of the Registrable Securities covered by the Registration
Statement; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify
to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(f), (ii) subject itself
to general taxation in any jurisdiction where it would not otherwise be so subject but for this Section 3(f), or (iii) file a general
consent to service of process in any such jurisdiction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(g)&nbsp;use
commercially reasonable efforts to cause all Registrable Securities covered by a Registration Statement to be listed on The Nasdaq Capital
Market (or the primary securities exchange, interdealer quotation system or other market on which similar securities issued by the Company
are then listed);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;promptly
notify the Investors, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening of any event
as a result of which, the Prospectus includes an untrue statement of a material fact or omits to state any material fact required to be
stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing (provided that such
notice shall not, without the prior written consent of an Investor, disclose to such Investor any material nonpublic information regarding
the Company), and promptly prepare, file with the SEC and furnish to such holder a supplement to or an amendment of such Prospectus as
may be necessary so that such Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the Securities Act and the Exchange
Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment
thereof, with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Investors in writing if, at any time during the
Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Investors are required
to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably
necessary to facilitate the registration of the Registrable Securities hereunder; and make available to its security holders, as soon
as reasonably practicable, but not later than the Availability Date (as defined below), an earnings statement covering a period of at
least twelve (12) months, beginning after the effective date of each Registration Statement, which earnings statement shall satisfy the
provisions of Section 11(a) of the Securities Act, including Rule 158 promulgated thereunder (for the purpose of this subsection 3(i),
&ldquo;<U>Availability Date</U>&rdquo; means the 45th day following the end of the fourth fiscal quarter that includes the effective date
of such Registration Statement, except that, if such fourth fiscal quarter is the last quarter of the Company&rsquo;s fiscal year, &ldquo;<U>Availability
Date</U>&rdquo; means the 90th day after the end of such fourth fiscal quarter);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(j)&nbsp;if
requested by an Investor, (i) as soon as reasonably practicable, incorporate in a prospectus supplement or post-effective amendment such
information as an Investor reasonably requests to be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price
being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) as soon as reasonably
practicable, make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters
to be incorporated in such prospectus supplement or post-effective amendment; and (iii) as soon as reasonably practicable, supplement
or make amendments to any Registration Statement if reasonably requested by an Investor holding any Registrable Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(k)&nbsp;within
two (2) Business Days after a Registration Statement which covers Registrable Securities is ordered effective by the SEC, deliver to the
transfer agent for such Registrable Securities (with copies to the Investors whose Registrable Securities are included in such Registration
Statement) confirmation that such Registration Statement has been declared effective by the SEC; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(l)&nbsp;with
a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation of the SEC
that may at any time permit the Investors to sell shares of Common Stock to the public without registration, covenant and agree to: (i)
make and keep adequate current public information available, as those terms are understood and defined in Rule 144, until the earlier
of (A) six months after such date as all of the Registrable Securities may be sold without restriction by the holders thereof pursuant
to Rule 144 or any other rule of similar effect or (B) such date as all of the Registrable Securities shall have been resold or shall
have otherwise ceased to be Registrable Securities; (ii) file with the SEC in a timely manner all reports and other documents required
of the Company under the Exchange Act; and (iii) furnish to each Investor upon request, as long as such Investor owns any Registrable
Securities, (A) a written statement by the Company that it has complied with the reporting requirements of the Exchange Act, (B) a copy
of the Company&rsquo;s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may
be reasonably requested in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such Registrable
Securities without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 5. <U>Obligations of the Investors</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0in 0.5in; text-indent: -12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;Each
Investor shall furnish in writing to the Company such information regarding itself, the Registrable Securities held by it and the intended
method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect the registration of such Registrable
Securities, and shall execute such documents in connection with such registration as the Company may reasonably request. At least five
(5) Business Days prior to the first anticipated filing date of any Registration Statement, the Company shall notify each Investor of
the information the Company requires from such Investor if such Investor elects to have any of the Registrable Securities included in
such Registration Statement. An Investor shall provide such information, including but not limited to a completed questionnaire substantially
in the form of <U>Exhibit B</U>, to the Company at least three (3) Business Days prior to the first anticipated filing date of such Registration
Statement if such Investor elects to have any of the Registrable Securities included in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;Each
Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of a Registration Statement hereunder, unless such Investor has notified the Company in
writing of its election to exclude all of its Registrable Securities from such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-size: 10pt">(c)</FONT> <FONT STYLE="font-size: 10pt">Each Investor agrees that, upon receipt of any notice from the Company of either </FONT>(i) the commencement of an Allowed Delay pursuant to Section 2(c)(ii) or (ii) the happening of an event pursuant to Section 3(h) hereof, such Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable Securities, until the Investor is advised by the Company that such dispositions may again be made.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;Each
Investor covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it
or an exemption therefrom in connection with sales of Registrable Securities pursuant to any Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 6. <U>Indemnification</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Indemnification
by the Company</U>. The Company will indemnify and hold harmless each Investor and its officers, directors, members, employees and agents,
and each other person, if any, who controls such Investor within the meaning of the Securities Act, against any losses, claims, damages
or liabilities, joint or several, to which they may become subject under the Securities Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement
or omission or alleged omission of any material fact contained in any Registration Statement, any preliminary Prospectus or final Prospectus,
or any amendment or supplement thereof or (ii) any violation by the Company or its agents of any rule or regulation promulgated under
the Securities Act applicable to the Company or its agents and relating to action or inaction required of the Company in connection with
such registration, and will reimburse such Investor, and each such officer, director, member, employee, agent and each such controlling
person for any legal or other documented, out-of-pocket expenses reasonably incurred by them in connection with investigating or defending
any such loss, claim, damage or liability (or action in respect thereof); provided, however, that the Company will not be liable in any
such case if and to the extent that any such loss, claim, damage or liability arises out of or is based upon (i) an untrue statement or
alleged untrue statement or omission or alleged omission so made in conformity with information furnished by such Investor or any such
controlling person in writing specifically for use in such Registration Statement or Prospectus; (ii) the use by an Investor of an outdated
or defective Prospectus after the Company has notified such Investor in writing that such Prospectus is outdated or defective; (iii) an
Investor&rsquo;s failure to send or give a copy of the Prospectus or supplement (as then amended or supplemented), if required (and not
otherwise exempted) to the Persons asserting an untrue statement or omission or alleged untrue statement or omission at or prior to the
written confirmation of the sale of Registrable Securities; or (iv) an Investor&rsquo;s bad faith, gross negligence, recklessness, fraud
or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&nbsp;<U>Indemnification
by the Investors</U>. Each Investor agrees, severally but not jointly, to indemnify and hold harmless, to the fullest extent permitted
by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning of
the Securities Act) against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from any
untrue statement of a material fact or any omission of a material fact required to be stated in any Registration Statement or Prospectus
or preliminary Prospectus or amendment or supplement thereto or necessary to make the statements therein not misleading, to the extent,
but only to the extent that such untrue statement or omission is contained in any information furnished in writing by such Investor to
the Company specifically for inclusion in such Registration Statement or Prospectus or amendment or supplement thereto. Except to the
extent that any such losses, claims, damages, liabilities or expenses are finally judicially determined to have resulted from an Investor&rsquo;s
bad faith, gross negligence, recklessness, fraud or </FONT>willful misconduct, in no event shall the liability of an Investor be greater
in amount than the dollar amount of the proceeds (net of all expenses paid by such Investor in connection with any claim relating to this
Section 6 and the amount of any damages such Investor has otherwise been required to pay by reason of such untrue statement or omission)
received by such Investor upon the sale of the Registrable Securities included in such Registration Statement giving rise to such indemnification
obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Conduct
of Indemnification Proceedings</U>. Any person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying
party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such
claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification hereunder shall
have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall
be at the expense of such person unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) the indemnifying
party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory to such person or (c) in the reasonable
judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying
party with respect to such claims (in which case, if the person notifies the indemnifying party in writing that such person elects to
employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense
of such claim on behalf of such person); and provided, further, that the failure of any indemnified party to give written notice as provided
herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give notice shall
materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying
party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate
firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified
party, which shall not be unreasonably withheld or conditioned, consent to entry of any judgment or enter into any settlement that does
not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability
in respect of such claim or litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&nbsp;<U>Contribution</U>.
If for any reason the indemnification provided for in the preceding paragraphs (a) and (b) is unavailable to an indemnified party or insufficient
to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to the amount paid or payable
by the indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative
fault of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations. No person guilty of
fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any person
not guilty of such fraudulent misrepresentation. Except to the extent that any such losses, claims, damages or liabilities are finally
judicially determined to have resulted from a holder of Registrable Securities&rsquo; bad faith, gross negligence, recklessness, fraud
or willful misconduct, in no event shall the contribution obligation of such holder be greater in amount than the dollar amount of the
proceeds (net of all expenses paid by such holder in connection with any claim relating to this Section 6 and the amount of any damages
such holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or </FONT>omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> 7. <U>Miscellaneous</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Effective
Date</U>. This Agreement shall be effective as of the Closing, and if the Closing has not occurred on or prior to fifth Trading Day following
the date of the Purchase Agreement, unless otherwise mutually agreed, then this Agreement shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Amendments
and Waivers</U>. This Agreement may be amended only by a writing signed by the Company and the Required Investors. The Company may take
any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company shall have obtained
the written consent to such amendment, action or omission to act of the Required Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Notices</U>.
All notices and other communications provided for or permitted hereunder shall be made as set forth in Section 5.4 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(d)&nbsp;<U>Assignments
and Transfers by Investors</U>. The provisions of this Agreement shall be binding upon and inure to the benefit of the Investors and their
respective successors and assigns. An Investor may transfer or assign, in whole or from time to time in part, to one or more persons its
rights hereunder in connection with the transfer of Registrable Securities by such Investor to such person, provided that such Investor
complies with all laws applicable thereto, and the provisions of the Purchase Agreement, and provides written notice of assignment to
the Company promptly after such assignment is effected, and such person agrees in writing to be bound by all of the provisions contained
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(e)&nbsp;<U>Assignments
and Transfers by the Company</U>. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without
the prior written consent of the Required Investors, provided, however, that in the event that the Company is a party to a merger, consolidation,
share exchange or similar business combination transaction in which the Common Stock is converted into the equity securities of another
Person, from and after the effective time of such transaction, such Person shall, by virtue of such transaction and without prior written
consent of the Required Investors, be deemed to have assumed the obligations of the Company hereunder, the term &ldquo;Company&rdquo;
shall be deemed to refer to such Person and the term &ldquo;Registrable Securities&rdquo; shall be deemed to include the securities received
by the Investors in connection with such transaction unless such securities are otherwise freely tradable by the Investors after giving
effect to such transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(f)&nbsp;<U>Benefits
of the Agreement</U>. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective permitted
successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than
the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of
this Agreement, except as expressly provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&nbsp;<U>Counterparts</U>.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or </FONT>any electronic
signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart
so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(h)&nbsp;<U>Titles
and Subtitles</U>. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(i)&nbsp;<U>Severability</U>.
Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as
if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted by
applicable law, the parties hereby waive any provision of law which renders any provisions hereof prohibited or unenforceable in any respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(j)&nbsp;<U>Further
Assurances</U>. The parties shall execute and deliver all such further instruments and documents and take all such other actions as may
reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(k)&nbsp;<U>Entire
Agreement</U>. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete and exclusive
statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. This Agreement supersedes
all prior agreements and understandings between the parties with respect to such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(l)&nbsp;<U>Governing
Law</U>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. Service of process
in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as
are specified for the giving of notices under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(m)&nbsp;<U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[remainder of page intentionally
left blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Agreement or caused their duly authorized officers to execute this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>SPECTRAL AI, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 2.4pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ J. Michael DiMaio, MD</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.4pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: 2.4pt"></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-right: 2.4pt"><FONT STYLE="font-size: 10pt">J. Michael DiMaio, MD</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Signature Page to Registration
Rights Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -184.45pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGE OF HOLDERS TO SPECTRAL
AI, INC. REGISTRATION RIGHTS AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 40%">Name of Holder:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">Hudson Bay Master Fund Ltd.</TD>
    <TD STYLE="width: 20%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><I>Signature of Authorized Signatory of Holder</I>:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Richard Allison</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name of Authorized Signatory:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">Richard Allison</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Title of Authorized Signatory:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">Authorized Signatory*</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> * Authorized Signatory</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Hudson Bay Capital Management LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">not individually but solely as</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Investment Advisor to Hudson Bay Master Fund Ltd.</P>



<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 26.15pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Exhibit
A</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Plan of Distribution</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 26.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The selling
stockholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock
or interests in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership
distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock
or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private
transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing
market price, at varying prices determined at the time of sale, or at negotiated prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The selling
stockholders may use any one or more of the following methods when disposing of shares or interests therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">-&nbsp;ordinary brokerage transactions
and transactions in which the broker-dealer solicits purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">-&nbsp;block trades in which the
broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate
the transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"> - purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -6.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"> - an exchange distribution in accordance with the rules of the applicable exchange;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -6.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"> - privately negotiated transactions;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -6.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">- short sales and settlement
of short sales entered into after the effective date of the registration statement of which this prospectus is a part;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">- through the writing or settlement
of options or other hedging transactions, whether through an options exchange or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">- broker-dealers may agree
with the selling stockholders to sell a specified number of such shares at a stipulated price per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"> - a combination of any such methods of sale; and</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -6.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"> - any other method permitted by applicable law.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -6.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The selling
stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and,
if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common
stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision
of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), amending the list of selling stockholders to include
the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may
transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will
be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In connection
with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they
assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short
positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also
enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative
securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which
shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The aggregate
proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock
less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from
time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not
receive any of the proceeds from this offering. Upon any exercise of the warrants by payment of cash, however, we will receive the exercise
price of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The selling stockholders
also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided
that they meet the criteria and conform to the requirements of that rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The selling stockholders
and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be &ldquo;underwriters&rdquo;
within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of
the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are &ldquo;underwriters&rdquo;
within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">To the extent
required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public
offering prices, the names of any agents, dealers or underwriters, and any applicable commissions or discounts with respect to a particular
offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement
that includes this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In order to
comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered
or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified
for sale or an exemption from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have
advised the selling stockholders that the anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934, as amended,
may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, to the
extent applicable, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling
stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify
any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities
arising under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have agreed
to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating
to the registration of the shares offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have agreed
with the selling stockholders to use commercially reasonable efforts to cause the registration statement of which this prospectus constitutes
a part to remain continuously effective until the earlier of (1) such time as all of the shares covered by this prospectus have been disposed
of pursuant to and in accordance with such registration statement or (2) the date on which all of the shares may be sold without restriction
pursuant to Rule 144 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B><U>Exhibit B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Form of Selling Stockholder Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ea026231501ex99-1_spectral.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY SPECTRAL AI, INC. ON OCTOBER 23, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="ex99-1_002.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Spectral AI raises $7.6 Million of Additional
Growth Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>DALLAS, TX &ndash; October 23, 2025 - Spectral
AI, Inc. (Nasdaq: MDAI) (&ldquo;Spectral AI&rdquo; or the &ldquo;Company&rdquo;)</B>, an artificial intelligence (AI) company focused
on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the pricing of a $7.6 million offering.
The offering will provide the Company with additional growth capital for the continued expansion and development of its DeepView&reg;
System.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transaction includes the issuance of 4,000,000
shares of its common stock and pre-funded warrants at a price of $1.90 per share and corresponding warrants with an exercise price of
$2.51 per share of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">J. Michael DiMaio, MD, Chairman of the Board of
Spectral AI, said, &ldquo;I am pleased that we were able to secure institutional funding for Spectral AI. This financing ensures that
we can continue to develop and expand the DeepView System&rsquo;s clinical indications and prepare for commercial readiness in 2026. We
remain fully committed to supporting our current BARDA Project BioShield (PBS) contract, while also advancing our AI-powered technology
to broaden our product offerings and deliver innovative solutions to the global medical community.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Northland Capital Markets acted as the exclusive
placement agent for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reed Smith, LLP acted as counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Spectral AI </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Spectral AI, Inc. is a Dallas-based predictive
AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving
patients with burns. The Company is working to revolutionize the management of wound care by &ldquo;Seeing the Unknown&reg;&rdquo; with
its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment
of a burn wound&rsquo;s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of
exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards
value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain statements made in this release are &ldquo;forward
looking statements&rdquo; within the meaning of the &ldquo;safe harbor&rdquo; provisions of the United States Private Securities Litigation
Reform Act of 1995, including statements regarding the Company&rsquo;s strategy, plans, objectives, initiatives and financial outlook.
When used in this press release, the words &ldquo;estimates,&rdquo; &ldquo;projected,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;forecasts,&rdquo; &ldquo;plans,&rdquo; &ldquo;intends,&rdquo; &ldquo;believes,&rdquo; &ldquo;seeks,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;should,&rdquo; &ldquo;future,&rdquo; &ldquo;propose&rdquo; and variations of these words or similar expressions (or the negative
versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees
of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important
factors, many of which are outside Company&rsquo;s control, that could cause actual results or outcomes to differ materially from those
discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investors should carefully consider the foregoing
factors, and the other risks and uncertainties described in the &ldquo;Risk Factors&rdquo; sections of the Company&rsquo;s filings with
the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important
risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>For Media and Investor Relations, please contact</U></B>:&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">David Kugelman&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atlanta Capital Partners LLC&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(866) 692-6847 Toll Free - U.S. &amp; Canada&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(404) 281-8556 Mobile and WhatsApp&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: dk@atlcp.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' * # 2(  A$! Q$!_\0
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MRA&B4CY@&VL,X(!'!%7W\):))HS:2UBHLS,TZH'8,LC,6+JV=RMDGD'N1TK
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@<D;E(P1Q3K.UAL[6*"!=L4:!$&<X4# HHHZAS.UC_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Y 0X# 2(  A$! Q$!_\0
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MRL9M@I"1KSCYOE]P<FN_HH \WL(==N8+>SFBU6(G3([=97)7$Q?,CLV>-H
G/>K=IIVKQ:]8W,@U'RI-3G9\R,RI"$VH"N> Q^:N]HH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>mdai-20251022.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qRZo7xRiXhun8uNbXQsSaqB6aPtypR1uYkxs2tzHSm6vywpiB/VjCHxLK1moZwF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:mdai="http://spectral-ai.co/20251022" elementFormDefault="qualified" targetNamespace="http://spectral-ai.co/20251022">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://spectral-ai.co/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="mdai-20251022_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mdai-20251022_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mdai-20251022_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="mdai_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" name="RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>mdai-20251022_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="mdai-20251022.xsd#Cover" roleURI="http://spectral-ai.co/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://spectral-ai.co/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mdai-20251022.xsd#mdai_CommonStockParValue0.0001PerShareMember" xlink:label="loc_mdaiCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_mdaiCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mdai-20251022.xsd#mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" xlink:label="loc_mdaiRedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_mdaiRedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>mdai-20251022_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mdai-20251022.xsd#mdai_CommonStockParValue0.0001PerShareMember" xlink:label="mdai_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdai_CommonStockParValue0.0001PerShareMember" xlink:to="mdai_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mdai_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="mdai-20251022.xsd#mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" xlink:label="mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" xlink:to="mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember_lbl" xml:lang="en-US">Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>mdai-20251022_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="mdai-20251022.xsd#Cover" roleURI="http://spectral-ai.co/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://spectral-ai.co/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mdai-20251022.xsd#mdai_CommonStockParValue0.0001PerShareMember" xlink:label="loc_mdaiCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_mdaiCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdai-20251022.xsd#mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" xlink:label="loc_mdaiRedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_mdaiRedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SPECTRAL AI, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001833498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-3987148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2515 McKinney Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">499-4934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdai_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDAI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember', window );">Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDAIW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdai_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdai_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0262315-8k_spectral.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://spectral-ai.co/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0262315-8k_spectral.htm">ea0262315-8k_spectral.htm</File>
    <File>mdai-20251022.xsd</File>
    <File>mdai-20251022_def.xml</File>
    <File>mdai-20251022_lab.xml</File>
    <File>mdai-20251022_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0262315-8k_spectral.htm": {
   "nsprefix": "mdai",
   "nsuri": "http://spectral-ai.co/20251022",
   "dts": {
    "inline": {
     "local": [
      "ea0262315-8k_spectral.htm"
     ]
    },
    "schema": {
     "local": [
      "mdai-20251022.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mdai-20251022_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mdai-20251022_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdai-20251022_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://spectral-ai.co/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0262315-8k_spectral.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0262315-8k_spectral.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "auth_ref": []
    },
    "mdai_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spectral-ai.co/20251022",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "mdai_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://spectral-ai.co/20251022",
     "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://spectral-ai.co/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001213900-25-102145-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-102145-xbrl.zip
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ME ,$^!_-4KVUNU-MW(MJ^,?-$Q%J7&+ XP[E9A1Y2.(6GLL1VXRSB.,2QY^
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MY>>'BRQ"X211%]PL%0/P!#,MJR@"I-,$JUZ[C_0+,U:K8[V%O&ARO9$?^[W
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M4Y;J2CUDRH-$=#SA<F(.3)\TRU4^*MSL<$=%.V>?H0R%[V[IO3@-!FTCZ5:
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MMXO6[2N^VUL#QUCB3_!:K?W_#U!+ P04    "  L@%A;]QMN\!?&  !5S00
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M742//'D(E]'\:EG#E, <5$D!"Y.7/#\U]AB?YP.,ZH'\XK*$&2W0E(!?R<S
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M"8C*0.!R(XYM3&BSS[3T/7I.U,2,;!<?7(8GR$S!+KOWUNY9["&L/DC\"54
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MI^&E(VW35E\4"5Q1.+S>-O#E(= "S>ZR;+A5>V/B&%CN3).LRLELK@69MP(
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M@MPNZ?3%ZBV?YW4P\]?!B=UXP\$+V)_])1<["CZY=E<K^?U,KAWUWIZ%.1C
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M!##0#$]CJL8NRY*, OP'3-9LD5]J+5+..U0\-FL.!HT:G,U(CZ8NW1.^<E%
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M_QT^@W1*U36JU/:YJ$AH@/Q'C;Z8AO08JC\@?IKYDCOD_2V&ZB(SP_:7I(R
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MK7Z_9,/" &--"<SA -4@6\P5M]>)$GFP$GU7&C5;F<"=I+(R9^PV7@^Z]^_
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MI$X=9I'0+3:IC,BM2/(\W#L4JWVK2OP]S#0_;",_FX_\_+"-_'PMGN3QF)T
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MBRQ4RN3>,Z"O5Q*#&N%+U.M8L6$^*F:N.7F6GDKAO_^"&_C^<%>LT6Z)D7/
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M$51*/M:>>R*ABY:/Z#?=Q#..3(9*J(MD\-W4*V.(DYNW%>VP(6,=<O-"X6_
M-_J<%3_/F$6,Z>79B** -NPOB$&;>&U38<E3,3$Q[GR@_RSHXN&N5.9M>M6[
M=(IR."#."HKA(+15N.K#M1L&N>A6(!+CZ#3QONDS*X;$P1_F:^<<>>'-X$,O
M+98&69W*>F$1:^V842^"+8YLFE*:&R 5%:9(&0C!*;ZD)?._Z^%^X U(57(]
M^R0A%U+<1'4+\3GJ41)!*KAO!&?H'2_Q6'T4["H>5G0=!ZO7,HNGA303UW*U
M>#UDX>6S13X2WBO],M4&\;;.1AHYK!T/"3O(SM88->TP=!AXNXPU)5L0DQN+
M3#C(1PLSD'.1JJ/^(A!&RBXOM)=Z@[ZBGG=F^!9HSS)/D(+R=3J9$ ,G;:1-
M4F@*GPX=6"=/@YS,(9I4H<6UPYF;"TI@ ?1X]O=\>T1CBN<;0$5\0_".'UWX
M!N[U\WQF0C=ADE!@'F@)&,HL< ')\ZJ1!X-.N.VCM$@GF:<7"1^F41J44] ,
M)M\P WUKPY[W90\@MR$PNG)&B,V/LBEX@C."9[-3P:(C'=8AW@XV0>B%$0/O
MXB67IQ/\OB@OE!6@"):HL+OS4O=4XFJ=3F%)C.D:"&V:5\D(402G&++&Q\%@
MS,$D4)9"=G20DVW+U(2T/+[@Z8@W.9@HQK&$WL$%?C8=6#TJ$%>Z(&HE1(BV
MHR)2D5&8$DB<Y'#%IZE?FBI[-[<(P-')158OG6"Q?@C$*V(),;#5+1V#3G"Y
MAJX<HQ F^(#4BW$/T$9YS(V/*14/&;MS!$."[2%S+D!!K'TMS]"*HK]&9&2N
M;FK:%9#7"UW?J<?\<Z]</UGI@IT,4W0V)7L\+CEX G>X3$KGQY3+O52\X^(F
M:!5%P:%(\@8=(R?'QKPR"MQX.K?'N.?N2-H9B8S_-WM87)R4>KJY2DHM/2GU
M='.5E/JC)*4>;WJ]XZQN5$W#9N"[> FMU!;@6DE0!2S!2BN)CID;+-P%2=F"
M&(HSUG!#PY_SZ]"*@>'38]\=IE-TK@014&C8T1(<E%XX#2]JPO29G].#4RGT
M!%/I_^"A0ER1UA>O0I0571?Q*=HV+!G/\Q#]X=(Y'5(6MNJMUC(N0D)I%(],
MPU&81)>^ L;CHG>$<Z0%J#Q)<5O[@]!D/'DN%A; +@@.,M8PB;M5<IY("]*$
MUA&_7;AR.!>T8< :1\RN.'P\:_Q,= P-^83&WFH*QZ=(R)I4YP3+Y!O<E:>(
M71)>)FZ*QVY4@[ZZ^:O]].&_X7C&D$TPYL*/1(-!K:<%-6K3.KJV2^ 8YG\>
M+@9JM[Q?PJ A1 8C_3T+C%Y/;$#G>#%6;D4,$'=YKVP*@+5>8BU4]!R,W9)Q
M CR>:QB=&4EDU'N6HRE@_RICP;3!')4);(2,"#I3:0[]K,HB&WEJ^^:$XNCL
M:KY.*6*'-9:'%1C8$*PH%/4UAGJR^@06Q"A/DXJ1?-5,-+DN!;NB<\J<Y09;
M->&N7]X,LP O:TF?3TI?[QF'/R"B:9EGI!>=VH<K:G7JK_[]YZ30S+;^SH0/
MN,KI*I-^Q@W@XV(!@I N\CWH0E^],0\B]QR4KJAUR)*/-TVEE]" @\ ,J:H<
M=UL;LMN4$@07,[GX)AOUJ%AT)!_:_;LB6/+A+U45;L:G7M'?7ZJ S..;49 Y
M\&1-",D$0TQJC'TR,@]SWNB]_O]Y^J[2BF5+@SM9&60#DBB)$7J;D[#=CYOP
MR_/:$ 6%;(;QA809#I;OZ)XPVX:[/X[HHHJ<9668T*>=S1:"GE*4R/?,,7TC
MWHUA0BHKL_PVXF#W6<4+\+Z2"&3:)J5)Z"5DQ :A\*S^4,_!^4Q]\A/IF0SL
MF>V14FO":+A/"[E:'\VD5>3KB.WMV^](3;"WE^3HG<I<]*BW&%[R_@/B3"VF
M4)?# U^7R#M390:+%@\';]_N&$=MARL8N%4FX;_ ,?[2IFR?INC"[C">'5H1
M'AU8GI=6Y,OI"TU;QA3?!)\17)<GC^/HR>:3K84%L.&;OMF@U[=@Q(ZN8,2:
MLS):>[(>G8-[>Y$IZ\V<@Z$A!C95!?)5B%1LWW!D7.P8 FG,;I1R<DH"J)FZ
M,F'9M4P8:8@@CLK5ST?4?<<<5TX0YW!:YJ>,LOP[O(-VWCX.EXDG;QC0Y,(/
MV0I_1+#6^'++V^@@";:OSOJSN')*N5>LYL=Z$1Q-/O -CHI3Z!65NIYBYH1E
M/T0AGF"OC,JHA@.Q'II.ZG#G&"EP2O6Z#&V2+SHTY&C#_ 6E\KD57/Q591@O
M=R:+?J;<BS8LJ@0?I@Q5Q,LKR@063<<2WJ<\Z98/CJZY]+U: )<NA.43?.VF
M:SA+T)T$BS$T?[ B%(<2L,(MG .7V1"XKQ\#TWO;;1D)[:G)/!^E#*Y"FF:L
M0BVG*J/-F_:+FTG;R#'>E2,.QHVX($M02!R$<2A=UJIM5#(A/^?EXGYJ:Z5I
MY5$K#R>3P%DQ*QKD%A&M"7(OR%C4LGP=5QN":D/&TS$2/P4^41 .0+0))D\I
M'$ MQ$_KB,!]BT:+Q278O P'LJ63YA$T[Y&T5M-ZNI$#IET6*7KV> O<Q+5G
MZPLY;HG.C^*T;=0!^W"UH0>E/:03[H&-O#.N^ICHPJ=PF6@N,Z5,@RI!9QT&
M#AXZ:\V5S^"G4:R(X&OB>8BOUO?8\!&\V.7VDB/B Y9@CK AKSYW4IXAJ7SL
M070MF66W;;+/$:RAYL0>6!)1-L=52EI%<OJ0'0FV3*]9XZ"=(W )%H6N!9?R
M_:)%H0GA=3MOSI$;#D+_JA4"2!V5:V\<,?TLX<NW95)H200; >\)L[>7T$-"
MGR\V-<L:O/8U\::Y@@1H>"V0VP]?@>&7RTCH/%!8HQA5J2+PBCF65'@.8E-^
M6]$8C%/SZ? 8B5O&5 Q7</3T/=F67/:%[>A<&&?8^6),U2#TFWJ69TJ X=R'
M>IT;RF"VL9N7GO?&(:)#>&\N=#&V,8S=4^6,/ --SF97)-"SXE]48$(B<7F6
M3@*POHDJS<!RTV'OBAIT*RC:#YGHQ^<6I04VJ073<E["J,PQPJF%' \_8'03
MU9I/'Z\2X\M/C#]>)<;_F!$Y5:)I$8ORO=8SB[8!M(^?& O,J>6VHD*T2U(=
MT9XSB0KM)VZE<K&Q=N82@__MQZQ"(_>H([ 0O'['[O_,4;WQ$*Q!H_G!=O'O
M.ZXHRK!\B::ZQ;(W+<<>P%TZ_8<.\FS='ZFEQ_-1"2.?JG#6<PDH_HB>E'@T
M=:KL*6>)"@?VO=25)9L<<$]MF-2OT:T8B7+#SB&4/<GKTK417^R3^3,I]M.K
M0=\K-I#2!:'\E6^BTFK(KO1--60WT$%7-4$.QG!PC %*;D2K8+I']M$II8S=
M<W)2KFSS-B>LF8E*(.2N]JC8-K@B.#3ME@,,#+81.E:WZ4&D]O&,8>34IVK.
MOG7X#.5?8\<3([%T^<3G'E?E?-9+1:?*Z[$5A:<;\VFI@)6#P'5VC-HKTW./
M.@*FQRN"[' 4'HV/P1ES$C8@$S,0]J]57?,5+BVRP.% DU&^J#9@"G0 ZZK#
M8164E?+;%8H$%[;1O.&[AB[B6G5V+%=9='!25HBI2@3"8G#8[:NMN<J9NA8I
M<2,L2S$*B/JX%<XN=I+GJ=34.YT>JI%3"/\E=<+ATRK,2<%@>/IR3<V-._=W
MC=Z%C/$)B<O5HRH[XF""(8&\F57 T?^VC'F+&^L*'>\PMG=*&*\Z I$;  K"
M!#28?8)L 3JIH[DQD46 $#.\(%"^S<=.H!\VL&BC S07KC,8NX QR]/C)#>H
MK%;MQOIEA/<Z4R&?@V+A?;%43V&9ZD$AET-2G8>I&"EAR2^1)\%@&CBR?@2Q
MYJ.6?*ZM^G"U<>=![7GD I B9J65C&EQC/>;"QDH*>:PB&+-1/""'7C]E?C5
M6S"R.]"KJ=$"I(!=,(*V?)2DD\6S6Y@2(Q_C6D-#,9B6HKCA(&S7U$^ZRD5+
M,&H8&5[.D-HM;<IB>D95J38C8=HDKMBVI@[]+2"#%%NP>$"_E* 3->V^1@[)
MGGE7YKETLXBDXCYN_47#?:EY4C.:U,I+X\4Q.>J.FEU(%)D] J<'>C66,E)J
M\FEZ BO$)RJ<1X^XUDF99P@FQ6]5M?PC_(BR*BU@<@77.V6L&E_W>YZJQ6D\
M)Y&SA6'-*P? TY'P.%D2E44M)6^(LY324,Z<7=326"RV&$\OO9H<P>]DD5-5
M-$<D>MU_3R0HW==QYP;#OFRWF*>*.K6@RU+C2HUNYR8('M-G"U;AW=[P[I-5
M>'?YX=TGJ_#NO=X8R[P5>SD/278.!SN4V9,0W$<&*)VP=!P"E- #(;[PI/(7
MQ4[>MRLK19=5K@<!,XL/8'*BL@)O=QR95!]YO9@L YL;A-HZ]0Y74H)JA8&4
M4P_94/Y54EZ6LGBP/=/:?>% ,O)K#(11K4(Y\]%1@3.>V5NWA1+-L=NN6XRE
M[ZSMH6;1E77"'?ZFE%BQ QYFCQ]X5>)HP0^OO>.SL*:L9\AZJ\C^@*?+,C>1
ME[QX"T/\Z./,7!T7\BQ3+@1CS3&'E)$S+2'?M@K4%%O191.>D9=Y)Z$V?$B<
M%A>Q6<F+T]K +\UG$K6)3315A'ED,UF>38KB=M[6PWI 7CS=\!VCUXPYQ"B(
MWGT$4\7(+3CL9_?3?9;%5:-=H9R*6E&GZ2='_(2C0-P'QJ]W 0KR+CN-6&V5
MK]HJGH_\P//:P781S6S>+-O]3$D%-"Z:IJG:-L.,UT^JCU-M7A/I6XS0%-A0
MBEN.+[.R!H3#T/Z$B<KHD5IGV],&D9F'3WTF/7.,#^ NL8UO@6$(#\LD(GJ;
MQFR1*+YCQ@)O+G3$\*6#MI*VJG:5I_C.<X/<5\Y0_Z5'T'R,6A(\#3ZL[>&V
MGY:$]Z*[M[8?^2"2T](#A_2UBZCDL:]F*Q[A&6O*&P5$0X_JFRJR(V982=QK
M7B@/E900]WT3[U!_G8/3PL"J[_M6"(&6B#?,%?58ND59:TA[&0G]JH+G"#^*
MI&-@.%)2:-!*E/Z@;G\3K4)\",WTM6$57:GSLL#+I:%VO\P0'2'7\5=9!;ZS
M+,\ R-/A'BRUFR]03".]8IKI_O7GNY^W]P_W=M[N#@=_O]%C8?D-_VWO8&?W
M[=OM=[OO/QX\K*9_,SG)K0U?4'OH/7TZ H>#PS 4+#1ISC%T-$0VN>[! =V@
MF"UA]SH<'/\J/$,AY3,H7(Z\KTE3ERGA'@2Y;AYRD3A?-_,%K=6KF2C62(C-
MBQUGEI]!Q9*17=.!7$ER>SI-A*8 B7\HSL"!U&P"9_K:UD\''S_\W)S\]!?\
M[[J[Z+R& 9R4>5Z>:>35U.&\C& .%':+$Q#C+P0+33]+O4 AXVMN9IR'2;B2
MIG%U'*5Q?WE:/(F8$"0JD90;@7,JDY&Q6/\#>II7"?D]787\EA_R>[H*^=WK
MC;'$0^>).W3>I%3T C9[5UAU VG.I#:9;9\^R5P J0?AULF3IY[_42[L":=Z
M.HR^=/<BAL;Q::9P"2+P)2)#C+$YL@2A!H%O5@T?&I)*')N[D:,*5JI4QR0[
M$_[8$64SM=$*8L-L(%YX.#>F=62,8XF](AM1&;7#!T'*IN=&A+W'_QXJ,PN3
M4])@K'4I55"^R6<HB<\(/^FX:HD\#_;R([AYL#Y672N-$N6N$0S'<Y2G#:8R
M P+']M$=\%7(,>V^,!R$',?K,5XMI[.H23ZG=EK\S^,Y)\;3TXRSH5WRP%#B
MCFKR'3M1$+@E]^8L12YVN5'U<D+W9''QBYWE&WYF=&ZC3$<\&A>J#^O7,=*W
MB@I]I4DRJ&"X/%>I"9_ZZ&F_GB^LDV,N=C.@,P)_"%!T=)*.B9VI40($FC_/
M>N!Y9GJ($&)"/7C^)6I>"W?7PN?VY9&UQA1<5]R$4OPM;W;_KN?(@9F.F3&+
M\QF>S9DM=:@D@2")A(CBQ;GNZFZH%&=#%M77/&MS#62)\_?D:4_3BM$%^H2Q
M45#N'^#5%OB:+>#1J>_([M9R#=PV6C]LD3W*F.+=\T(29,S6R\8TLX<$7BGP
MNM(TCH?651CZFZ"E!E?!9<)Z>*XEKIL[AA=P76/J*@SE>I@F%;+IX>6'11H=
M_*F<,/!)I$GIR+;RI66K,Q@9,R?/:99$J 2;(Q$]>!0<SA2-"/[]>$PXG,#6
M2[-JF,J$RG'1-ZWE&=)[3$PT#!K+N*!PZ\73S6BV,=V(UG &_U%6GX:#'=(6
MAJZLA[1S<*UD64?V(#XWP86S!0*[UZ- W1HGBB\4K9^@.YB71:R:I#9[!BIJ
MC1,79)B1&JTK/*Q$\-D3NJT7XRO>UA&%AAUEN!0,7LK2"Q\W#C8BOHY+[F=4
M'A?,LPR#5]"-'/GW,USI:74JHXURF,QQ0(753I1<X4AZ>3\[*:=VIB@*[388
M[RG:%WQ4Z30X;F/=N<S%&6Q:+WERC3EC*=6F7-48W*..;&UX,,6VLC#5+X>#
MWZEVR-<TM:J%^N)\E G6S'"&__)43J(!(07?GE,[<1$V]OOI>;B"X.LND^3
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M/5I#Y3"V9M =UTP[2&V;IF'T?A<X7AFU>VO4GHA1HTOG<,"W3MA^)V#;8+N
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MK4VW.OAM-MCX85C]/;)2FI5P@Y_OV,+B #K:J[(G_V8KD!*S+MLF0Q,;P6(
M[>#@MA6X"-R^8H_V81X!I^2C&OQX?-8/+J!;-X.&",5&P)I9YCV:<)P/^5ZU
MX/KX'SP0"KJ-A&Q?Z=#.L8<#&(7MH"?S\]@6CNX=RI+ :K'>!8GTA.Y#[VNL
ME*?LM9,5"DV[/3GA37%$ZGU9D'2L9U<OF-:Q65)J/.(/Y2R?PSIP_:Z +]1T
MH*^3:4QS1+I%,@H\S46TZ<YTQF#3!6)^NN#O R.BNBT<48J'ACP(LMU;1SL
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M43S7SS,8QQ,XW&#\LZ8V^QI1]\A_![N@# S';0.1>DB>AL5J=S36P: BJ+0
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M&N1$44-CIH='UFVZ9#M\'B4+D$^G@&N)C@;7^[$C&#5<ILL:G\)]N<>>)W9
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M/$+Z#]NSI$VYJ 35M?WO\#M(9=-<H5%AOY=4&4V0_]&BA\LV&W'1BO>[V?&
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MU"8@_!.J)0R':R%-:2\EHX$"\(!(20D6886X$.R\AF@TL('I?QUPP<*R%,3
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M5US6-VOHO2:<9J8!H@T?%>VEY- +Y@LT7QZ>7!K6_VF #F[7W=SW8]@Y0;3
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M9/Q:1P$G@U&#CCAT@T43FP%^1I>#I^7IZTL?ZW=XO7Z1F/S.I'[P<L"/$=T
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M9' %-%6^<QS)?3G9DVH<,@C[6SF=\/G<2=!,8X@$[\&$WERK]_*WH#)8?[B
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M=+]?'E=2DF/@*PD'&Z>>S^,AG/2FE4_\%,ES5]M$%?UDC <";NL45=A8D^0
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M)FZ^0=G*,1#<:D*ZVR)""X "I6!FZMNR]1M&9=;XNC0/?(-Q@&B8=ALJY*C
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MIQC]]#):!>^B$A':-QBR_+9"7'Y =]WOUEV_>+%-U:+CH]:'7SWF\Z,75HC
MKAY86Y$_S[ER!._V\_M'+[YHQUFS/48M#326@S1-2JQ"<&W+NHFMU(39M85?
MN&FW>\-($;[B'>MZU7^O7X/1D+\IJ[\2+&E=#NQ_=V[OU\B=SFEO-!F'U;Z*
MEDD5I<!R,U!)"'EZ^_%F9L5Q"-/D/)G6IK(PT!.50BIO9DX<44[;<H -GCB[
M:%!4=:4TWZ"9]V6[="E=O:'LG02OP/@]>O_[X0W9.0]ONYWS\%;8.1,L,/15
MWC)&3CU&O_]D=V_0^/FBL0</L>OFP)Z9GJ%@Y: _\N:F<M-;\3%EK.PU0B*F
M]-65S.9*B>(:/+?B33H],\V],;C%5JG7A>4BB6 5Y[2D5I7!-,^HLOTR5=,Y
M_4LGQ$HI/0ZJLNDH,/*.J5>I^XE3QA[YDV+.N:,IV)A657*OX^[G3$:7DU]G
M"T=P.*<N72[EE<S =JD<*31/9I5>34C.M QVX2Q9CD=3ASH:&0,SS'U;1*NP
MG6T<TEBAEZ9L\\2XYZ+QY4O0OXE.^LI]D20B_D/G0^)$"VR2D]/D*41D%L52
MI-S-?Y2W8B "/LCQBE2.(3FG$HANR!M%,Y2JW462R\'.DL]8A*S P) 0/U@6
M"JN^<8 *S8>_U#4_35IDA/DBD?F:ZCPIT_3&O@9K5-KWT$_.HX(+G/%/G;);
MG8/@[E=80"NO$AJ#?_<M RGD.GYW;(!.$KO?$)4Z.?/B83!E6TR@T 7671%B
MX+ @3:0N[4H]OJ>W8XL;0^SP&#GVJ<>.$I,B_Z0* N"=B\-I!%[TJ)>%S+_:
MF2J@T8(4NQB+O"XEH[\HKW<1WVZ?)BFR*>(T_A:,1_X>4&\L#$M<<)D^I%B/
M84E?-$YN0\HU'7BY41K]( IT>46A81Z?"O"">$N66+(TUZR1^9T?YOO#;WRP
M8\BHY%H^_D9[>R%;%]EL9O_AF6Y)%U.BW+-N0_-*/ A/=G^Y=F3<[!!U5)52
M IX*T([LY&2,6OJJ4EBPS2;0+[DU&R-J0+IR1:;+QV['2G> K0"CD'ZYE-1E
MRA]SP7#G:S(H=(&(KFH/;D$SM\.BWSM)LSY?=S7U+WYXQK,#:ROR>LXW1A>"
MP4(=_M;F2\GLU]KV&>CEE/7DD!F:*$HRY/FE:,W)+]TJ($;MO@7[Y_%>W:X=
M;*[QR#"B#ANG-.(R<B*XLQH;<YHT-"U%*WRH2I9U:I5A3);B!W[X/436[M6!
M<0O4:RU6; .J]W\KN!D)-)T5)PGN TE\UUD!\QH7_=6V3J<ASZ@ ]<TLL"1V
MI.N_K&P'#C3&L7VS9\GWVN<7M@@3%0@**26SPE;04\6EO'4A=:YB2*J&A0=P
M>#3+W?H=]+2@,<Q2^2&=[8.L(I\A$L&RS->=S11E3SHWPDGLL.(IY&Q&0E(R
MIS^<KL?L"#)^ZAB[(C_:?[0UV=YZZ-1@<"C0)$^:6C#-)MBS8.^7AP\I]597
MIMS"YZ1F$*4!N[] H%-*!FV'_!.=19N",*8+W\,W!?.2$BR\PR[<U85V!825
M"6U0=<*.=W=N)V>'=#X?I=1 =R4 S$R4C!XB@QE(=<6DB.L%IH(1!N/U=?%*
MV7F WMI5H35&37]<F<-5=K#<.1$Y_ 3- UW,H@.8^XX:JNT]NNWNF4>WPCWS
M_;=4TZD:;MZ>JZ!)3?>\+AIRH0,B"_MU.N3HRG9HZ=*1V3SUE4:"D?EJ8WYL
M1K<UD6(_6K%&!H'O1S%4%]B5;,[959[9(\RYR7?X,VH6#T^8>2'[-! Q"KOQ
MB"O-#? \4G"1[Y' LJRNM7<\+3<GO")<VBG5AJG;*:'NG+I-0'N.57W,M+@,
M5AYQ+B7+_=8*,4G85\--$4/<*IRR%J_>!#98YGCD'"C;,@V7P\#!!FO.50J&
M!3&V;!#-U\5T829HV7.BL]TV7=N $N#9R<([;-N?^8C0\#1<2!C5$:T)-90*
M&E5J.I9?, KNJ"!^('[*.NI62;"[N=O-W/2X-44*L0B5-(MP#F#[CGD'HCE8
MF7-"0TT##W'%=!(T:X^-!A8^LW,/7RT8W15U0J.38GQV_!PS.TMLO%T2ZEAR
M>ZN%E/ JJ5\=&#S2)5RKXUTS12(ISA6WLK--XF*N:Y=A*7E=&4US<*H?0)GV
MN$Q0QSPMF<@&<^C]>L2F^K!4!T&-:&I7VE3?N!(!5;?F[N+IBN^O0!TT_F[P
MA^*-R_+*-!%A2Z_1.E@.))%;!]NP&_RNRPVJSZJ($]MI[R(JT-(A<'@9K30\
M!1KCF5.Z]4+&UL-R;15^$Y*)<W3ZA7?LUG01'-9L8#W>>"308"S:C@GA?:C(
M+U6FW:5-CQ'V!B3SD(I'DG&U]^B1,2Z:II,MPHL&#?M#5\%"J4ID0T(-_W0U
M RJT+Q==1 #7F* YPL\1]O[/J8HW#^\2;?P%;2,6UVU):.$<M'D=W5C[^66'
M<J@=[6+UND.;TKO#3;?VM_;V>IIN<7-?PV%#G[\";<1<5*64NA-8796(245%
MIF,0Q'/$I4,-2<NTS7QQ4I:5,^F9L7I)&:ME=#!TX+@4NW MFV+$E*Z38N(1
MC$IAM*/V?6FMX Y='+?V%HHJKJ<4-B",EE[/<A ,9WDTBQ;6\.BZB:'P*EO+
MUU,FF+R6]23%LJ):%IH(%6\(:C!"US4,G!OLWW!][QWXRB5>>-Y2=K/B3B0<
MH$ZC0B9C"<QM:!&QSY&*:DN]-TUN5GN%L5COL0T#0Y(J9;7C=/#Q$;H^=Y1(
M!Q/P]2UQF^^+<H_0!",.E$M7AE7@.%O,?=:5?0@'IGTL]7$(881MKJZ+]%!/
MRTQ,1K=J7<D5(;7>QX>%BC.9\?!B[)LW%3G#Y,:4NAL<81MI+I(=&H":)]8]
M$6D30).1<N?49[/4'?'TV#C,7S5L'K>B18R/V7S!;G.,T#!-&3WZLC^4[J$>
MDT1/I^D)2H6YI-PONJMPSV^<[-9 B(]O.X3X^"Y"B#\ DP([$ N_@!J*V2#2
MNZ';HZ';:X ]ENS !-C32W=1A[ <J[G^[%VW^G6H_>O6&_/(]<:$&);)0I%A
M(HT76J.&E"^V::1$(LT*I91IJ=&["M,[")N1)RG*NB;'XQ>.1U+NTV7#VG)=
M8!W(.%^:T=K@4&)*L/?!1"U'V7;@-39VUM!P..H2:N(?8:]SE93<GO<KU,IA
MH-$T >:>:SZLUK1+^*A\F_,\3\_U#%U[14<0S"-$XH ;%5C(T&TK$ :VX+OS
M,=:62RA>M%?7OVG&_\VOLG0RI*+!YL0&+H1L^OK-[MUC=@Q33<*&6A.:-KNF
MAK$OU1ON[CY8]PZ?XMKP'(RR1HT,\3/*,C0%:"F.+,?V"E1\MA:W[67#R&Q#
M![QO=,<9J\02>E1U-,GJO,8.'M9: +,EX4 !L.I!#:-PH2VPCAD01ZZ'3+\5
M\A#GYSTTX+9(X"R(*7GY792>:[*VPBQIS+YE%\'6_C:[)RC63KNYVW-S=6Y=
M6QMAE2(13YT[%0.H?9\&_!I]],EMUT>?W$5]E(K Z2%?]B;P?14-FG3!ET[&
M8/"2$P:O?\QOM[HWB' 3^,=\^<1)#?M'#6P!6$(6@<)UNY;MC3'$0GYZ%GS@
MH-JGP=L(-(Q;R4=^VIR/?!,C<Y@F[K_\\/I?5)?BM]-W;U_\?U!+ P04
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M ^H!>9?D0W D\$HZOQP&]\8JGYI\B50C/"'P-?0>BY*4Z,$Q0RA&PDKJ!1Q
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MD#%HZZC:X,4'+FP+PD@"-&AG+XK,C^H1QE(1-AUC*YFF8091$U9?4'#X^H1
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M5<_&Y<,!F0ZX@Q,MO@/ACNQ[YU-P7A:&JU$5M+*@BX$PJR:,O(+\<<8G;'0
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M?O?BS>&_2!C_=/[ZU?/_#U!+ P04    "  L@%A;9]\HJ15'  "5= $ '0
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M8;@!F2SX(U>'C&K0=-&RF:J]31:+/)LDXSQX .#L7&5X6.$=]0SI5463I+X
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MK'23>L@)IE2C9&K>1'/DLJ7A.25<ENQ.E%0Q>&A2I9@,*\D1Z*+$G.AP_H&
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M3,YKTV] ,IIT*RP73CX$Z.P%6UUH:1=V.*,R&%:V2ZS)KE(;[*YCZ4%<;0W
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MQTHQRIG2%>1KQO'0]G-)P&GR(C:53*X0M1+A;B*ZE-O7N.-V>:5RK<8,&:Q
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M5:V9BRSJE'M)-5='Z8-3,^5T+B+QXX15=$(CG'A==*4QA!#:@Q7[]#.Q0?H
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MBD'<9;&>,/-+_@@?V*RTU:=+-ZX*)CO%&H>86*P9-&.,KRH06BCIN$_@4&?
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MO:RX>.UXUJ/>-4-A\ECIA=:/"K5*BV3J+%PV*N&;^X=+B[_H^Q1_\!9%]6Y
M[14#+_RX^ZM7$<(+!J3#YDL1#_9ZQ3\%\&,UU?H%N-"TZN];++^!_F^M_$.3
M-C:O/?S 6X6H^?=!3M@Y>HF?K-<9(/A&H?0_JD\/S %;?V_C_^?4A[/C]O(2
MVWRY&GW:;<,COIIP0&^/^=?)Z*VS_P!02P,$%     @ +(!86Y\_$*'F"
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M:* T4H2?2^UJ&S)'^&X'HE.HUY892V]**X0[%%VL_;:\*!;6IG6L+!*K4#J
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M!#\16%*@%>I#O"$C;'UZ#2/BY[7,B^;$.F)UJ3_8+;!"&RT^S!B4W=6CL&%
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M&09=V[O2V+1F/NXM<U<*9[@,3]KG-@I2G3(H>G3&6M.PMY+/_8BRON5B/V2
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M&U!+ 0(4 Q0    ( "R 6%MIR[[+2B@  (_8   9              "  0
M  !E83 R-C(S,34M.&M?<W!E8W1R86PN:'1M4$L! A0#%     @ +(!86_<;
M;O 7Q@  5<T$ !X              ( !@2@  &5A,#(V,C,Q-3 Q97@Q,"TQ
M7W-P96-T<F%L+FAT;5!+ 0(4 Q0    ( "R 6%NL%KA 5X(  ([5 @ >
M          "  =3N  !E83 R-C(S,34P,65X,3 M,E]S<&5C=')A;"YH=&U0
M2P$"% ,4    "  L@%A;R?W9A\0[  !_1P$ '@              @ %G<0$
M96$P,C8R,S$U,#%E>#$P+3-?<W!E8W1R86PN:'1M4$L! A0#%     @ +(!8
M6RE8O5>16@  SMT! !T              ( !9ZT! &5A,#(V,C,Q-3 Q97@T
M+3%?<W!E8W1R86PN:'1M4$L! A0#%     @ +(!86V??**D51P  E70! !T
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M,#(R7V1E9BYX;6Q02P$"% ,4    "  L@%A;3W41H2T,  "3D0  %0
M        @ &J< ( ;61A:2TR,#(U,3 R,E]L86(N>&UL4$L! A0#%     @
M+(!86PP*=<]I"   VV,  !4              ( !"GT" &UD86DM,C R-3$P
@,C)?<')E+GAM;%!+!08     #  , & #  "FA0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>ea0262315-8k_spectral_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdai="http://spectral-ai.co/20251022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mdai-20251022.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833498</identifier>
        </entity>
        <period>
            <startDate>2025-10-22</startDate>
            <endDate>2025-10-22</endDate>
        </period>
    </context>
    <context id="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833498</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdai:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-22</startDate>
            <endDate>2025-10-22</endDate>
        </period>
    </context>
    <context id="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833498</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdai:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-22</startDate>
            <endDate>2025-10-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-22" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-22" id="Fact000004">0001833498</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-22" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-22" id="Fact000010">2025-10-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-22" id="Fact000011">SPECTRAL AI, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-22" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-22" id="Fact000013">001-40058</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-22" id="Fact000014">85-3987148</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-22" id="Fact000015">2515 McKinney Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-10-22" id="Fact000016">Suite 1000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-22" id="Fact000017">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-22" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-22" id="Fact000019">75201</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-22" id="Fact000020">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-22" id="Fact000021">499-4934</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-22" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-22" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-22" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-22" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000026">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">MDAI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-10-222025-10-22_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember"
      id="Fact000029">Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember"
      id="Fact000030">MDAIW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-10-222025-10-22_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-22" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-10-22" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
